Toxicity tests with crustaceans for detecting sublethal effects of potential endocrine disrupting chemicals by Wollenberger, Leah
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 20, 2017
Toxicity tests with crustaceans for detecting sublethal effects of potential endocrine
disrupting chemicals
Wollenberger, Leah; Kusk, Kresten Ole
Publication date:
2005
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Wollenberger, L., & Kusk, K. O. (2005). Toxicity tests with crustaceans for detecting sublethal effects of potential
endocrine disrupting chemicals. Kgs. Lyngby: DTU Environment.
Toxicity Tests with Crustaceans
for Detecting Sublethal Effects of
Potential Endocrine Disrupting
Chemicals
Leah Wollenberger
 
 
 
 
 
 
Toxicity Tests with Crustaceans for Detecting 
Sublethal Effects of Potential Endocrine 
Disrupting Chemicals 
 
 
 
 
 
 
 
 
 
Leah Wollenberger 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ph.D. Thesis 
 
Lyngby, March 2005 
Environment & Resources, Technical University of Denmark 
 
 
Toxicity Tests with Crustaceans for Detecting Sublethal Effects of  
Potential Endocrine Disrupting Chemicals 
 
 
Cover:  Birte Brejl 
Printed by: DTU tryk 
Environmental & Resources DTU 
ISBN 87-89220-77-3 
 
The thesis will be available as a downloadable pdf-file from the department's 
homepage on: www.er.dtu.dk 
 
Environment & Resources DTU 
Library 
Bygningstorvet, Building 115, Technical University of Denmark 
DK-2800 Kgs. Lyngby 
Phone: 
Direct (+45) 45 25 16 10 
  (+45) 45 25 16 00 
Fax: (+45) 45 93 28 50 
E-mail:  library@er.dtu.dk 
 
 
 
Contents 
 ABSTRACT V 
 RESUMÉ (IN DANISH) VII 
 PREFACE IX 
1 BACKGROUND AND AIM OF THE STUDY 1 
2 THE ENDOCRINE REGULATION OF CRUSTACEAN DEVELOPMENT AND 
REPRODUCTION 5 
2.1 Overview of Crustacean Endocrinology 5 
2.2 Endocrine Regulation of Molting 7 
2.3 Endocrine Regulation of Sexual Differentiation 9 
2.4 Endocrine Regulation of Reproduction 10 
2.5 Vertebrate-Type Steroid Hormones 12 
3 MATERIALS AND METHODS 13 
3.1 Selection of Test Species 13 
3.2 Development of a Fully Defined Marine Medium 13 
3.3 Copepods 14 
3.3.1 Overview of Copepod Biology 14 
3.3.2 Acartia tonsa 15 
3.3.3 Nitocra spinipes 16 
3.4 Copepods as Test Species for (Sub)chronic Toxicity Testing 16 
3.5 Endpoints Investigated in A. tonsa 20 
3.5.1 Larval Development Ratio 20 
3.5.2 Sex Ratio 21 
3.5.3 Egg Production 21 
3.6 Full Life-Cycle Test with N. spinipes 23 
3.7 Ecdysteroid Receptor-Based in vitro Screening Assay 23 
3.9 Test Compounds 25 
4 EFFECTS OF POTENTIAL ENDOCRINE DISRUPTERS ON CRUSTACEANS 29 
4.1 Introduction 29 
4.2 Ecdysteroids, Juvenile Hormones and Insect Growth Regulators 30 
4.2.1 Ecdysteroids 30 
4.2.2 Ecdysteroid-Mimics 32 
4.2.3 Juvenile Hormone-Analogues 33 
4.2.4 Chitin Synthesis Inhibitors 34 
4.3 Vertebrate Steroid Hormones and Xeno-Hormones 35 
4.4 Model Compounds 40 
5 CONCLUSION AND PERSPECTIVE 55 
6 REFERENCES 59 
 I 
Abbreviations  
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Abstract 
New and updated test methods to detect and characterise endocrine disrupting chemicals 
are urgently needed for the purpose of environmental risk assessment. Although 
endocrine disruption in invertebrates has not been studied as extensive as in vertebrates, 
in particular in fish, numerous reports on effects of potential endocrine disrupters on 
crustacean development and reproduction have been published since the beginning of 
the nineties. However, most crustacean toxicity test protocols routinely used so far have 
not been designed with endocrine-specific endpoints in mind. The main objectives of 
the present Ph.D. project were: 
1)  to develop a fully synthetic saltwater medium suitable for laboratory culturing of 
marine copepods including their feeding organism as well as for toxicity testing 
2)  to identify sensitive endpoints related to growth, development and reproduction of 
the pelagic calanoid copepod Acartia tonsa 
3)  to elucidate the applicability of those endpoints for testing sublethal effects of 
model compounds 
4)  to investigate these model compounds in a second species, the benthic 
harpacticoid copepod Nitocra spinipes 
5)  to study the model compounds in vitro for ecdysteroid agonistic/antagonistic 
activity with the ecdysteroid-responsive Drosophila melanogaster BII cell line 
6)  to draft an OECD guideline proposal for testing of chemicals based on the 
experimental work performed within this study  
In preliminary investigations with A. tonsa were studied various parameters related to 
processes regulated by hormones such as growth, molting, sexual maturation and 
reproduction. The primary endpoints were larval development ratio, egg production and 
sex ratio. Exposure experiments were conducted with naturally occurring and synthetic 
vertebrate and invertebrate hormones as well as compounds known to act as endocrine 
disrupters in vertebrates. Larval development ratio was identified to be a remarkably 
sensitive endpoint. The larval development test with A. tonsa is rapid, cost-effective, 
easily to perform and results in full concentration-response relationships allowing the 
determination of effective concentrations (ECx).  
After having demonstrated that larval development of A. tonsa was a very sensitive 
endpoint for evaluating effects of chemicals that might interfere with the endocrine 
system of crustaceans, the larval development test has been applied to two groups of 
emerging environmental contaminants, brominated flame retardants (BFRs) and 
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synthetic musks, known or suspected to be potential endocrine disrupters. In parallel, 
these compounds were investigated in a full life-cycle test with N. spinipes. This test 
allows studying larval development ratio as well as other individual life-table endpoints, 
which enable the calculation of population-level endpoints, e.g. the intrinsic rate of 
natural increase. In N. spinipes, larval development ratio has been proven to be the most 
sensitive endpoint too. The knowledge about the impact of BFRs on aquatic organisms 
is still limited. A primary contribution of the present work with BFRs was to establish 
data on their (sub)chronic toxicity towards marine copepods. 
To discriminate between general toxicological and endocrine-mediated toxic effects, the 
model compounds were assessed in vitro for ecdysteroid agonistic/antagonistic activity 
using the Drosophila melanogaster BII cell line assay. The pentabrominated diphenyl 
ethers BDE-99 and BDE-100 showed weak ecdysteroid antagonistic activity. Thus, they 
are able to interfere with a crucial physiological mechanism in arthropods, a property 
that only is known for a very few substances. The combination of in vitro assays and 
(sub)chronic copepod tests, as applied in this study, is a valuable tool when screening 
chemicals suspected to be specifically toxic, in particular, to interfere with the endocrine 
system. 
The results of the experimental work as well as the literature survey demonstrated 
clearly that marine copepods such as Acartia tonsa and Nitocra spinipes are suitable and 
very sensitive test organisms to study sublethal effects of specific toxic chemicals 
including compounds suspected to be potential EDCs.  
Another outcome of this study, which is of particular importance for environmental risk 
assessment of chemicals, is the OECD Draft Guideline for Testing of Chemicals - 
Proposal for a New Guideline, Calanoid Copepod Development and Reproduction Test 
with Acartia tonsa. 
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Resumé (in Danish) 
Ved risikovurdering af kemikalier er der et stort behov for nye og opdaterede 
testmetoder til påvisning og karakterisering af hormonforstyrrende stoffer. Selvom 
hormonforstyrrelser i invertebrater er mindre velundersøgte end i vertebrater, specielt i 
fisk, findes der en lang række studier af forskellige effekter af potentielt 
hormonforstyrrende stoffer på udvikling og reproduktion hos krebsdyr. De fleste 
rutinemæssigt anvendte testmetoder med krebsdyr er dog ikke blevet designet specifikt 
med henblik på hormonsystem-relaterede endpoints. Formålet med dette Ph.D. projekt 
har været: 
1)  at udvikle et fuldt syntetisk marint medie til laboratoriedyrkning af marine 
copepoder og deres fødeorganismer samt til toksicitetstests 
2)  at identificere sensitive parametre relateret til vækst, udvikling og reproduktion 
hos den pelagiske calanoide copepod Acartia tonsa 
3)  at vurdere anvendeligheden af disse parameter til detektion af subletale effekter af 
modelstoffer  
4)  at undersøge effekter af de samme modelstoffer på en anden copepod, den 
bentiske harpacticoid Nitocra spinipes 
5)  at teste modelstofferne in vitro for deres ecdysteroid agonistisk/antagonistisk 
aktivitet ved brug af den ecdysteroid-responsive Drosophila melanogaster BII 
cellelinie 
6) at udarbejde et udkast til en standard-testmetode for undersøgelse af kemikalier, 
baseret på det eksperimentelle arbejde udført i dette projekt 
I indledende forsøg med A. tonsa blev undersøgt forskellige parameter, som er relateret 
til processer, der er under hormonal kontrol. Sådanne processer er blandt andet vækst, 
hudskifte, kønsmodning og reproduktion. De vigtigste endpoints var 
larveudviklingsratio, ægproduktion og kønsratio. Eksponeringsforsøg blev udført med 
både naturligt forekommende og syntetiske vertebrat- og invertebrathormoner, såvel 
som stoffer kendt eller mistænkt for at forstyrre hormonsystemer i vertebrater. 
Larveudviklingsratio blev identificeret som et specielt følsomt endpoint. 
Larveudviklingstesten med A. tonsa er hurtig, billig og let at udføre og resulterer i fulde 
koncentrations-respons-sammenhænge, hvilket giver mulighed for beregning af effekt-
koncentrationer (ECx).  
Efter påvisningen af larveudviklingen af A. tonsa som et meget følsomt endpoint for 
tests med kemikalier, som muligvis påvirker det endokrine system af krebsdyr, blev 
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larveudviklingstesten anvendt på to grupper af nye miljøfremmede stoffer, bromerede 
flammehæmmere (BFRs) og syntetiske moskusstoffer. Begge stofgrupper er kendt for 
deres hormonforstyrrende egenskaber i vertebrater. Samtidigt blev disse stoffer 
undersøgt i en livscyklustest med N. spinipes. I denne test blev larveudviklingen såvel 
som andre individuelle livs-forløb endpoints undersøgt, hvilket muliggjorde 
beregningen af et endpoint på populationsniveauet, den potentielle populations-
vækstrate. Ligesom hos A. tonsa var larveudviklingsratioen den mest følsomme para-
meter hos N. spinipes. Viden om skadelige effekter af BFRs på akvatiske organismer er 
stadig begrænset. Etableringen (sub)kroniske toksicitetsdata for BFRs med marine 
krebsdyr er derfor et væsentlig nyt vidensbidrag.  
For at kunne skelne mellem endokrine og andre typer effekter blev modelstofferne 
undersøgt in vitro for deres ecdysteroid agonistisk/antagonistisk aktivitet ved brug af 
Drosophila melanogaster BII cell linie-testen. De polybromerede diphenyl-ethere 
BDE-99 and BDE-100 udviste en svag ecdysteroid antagonistisk aktivitet. De er derved 
i stand til at vekselvirke med en afgørende fysiologisk mekanisme i arthropoder - en 
egenskab, som kun er kendt for meget få stoffer. Kombinationen af in vitro-metoder og 
(sub)kroniske copepodtests, som anvendt i dette studie, er et værdifuldt værktøj til 
screening af kemikalier, der er mistænkt for at virke specifikt toksisk herunder med 
direkte virkning på det endokrine system.  
De eksperimentelle resultater såvel som litteraturstudiet viser klart, at marine copepoder 
som Acartia tonsa og Nitocra spinipes er velegnede og følsomme testorganismer til 
undersøgelser af subletale effekter af specifikt virkende stoffer inklusive potentielt 
hormonforstyrrende stoffer.  
Et andet væsentligt resultat, som er af betydning for risikovurderingen af kemikalier, er 
forslaget til en ny OECD testmetode: Draft Guideline for Testing of Chemicals - 
Proposal for a New Guideline, Calanoid Copepod Development and Reproduction Test 
with Acartia tonsa.  
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1 Background and Aim of the Study 
Over the last ten years there has been growing concern about low-level exposure of man 
and wildlife to xenobiotics capable of modulating or disrupting the endocrine system. 
There is strong evidence that potentially adverse effects occur in wildlife at the 
individual and population level caused by disruption of one or more endocrine systems. 
For example, male fish with detectable levels of vitellogenin, a female-specific protein, 
were seen in various rivers in United Kingdom and the USA [9-11]. Imposex 
(development of male sexual characteristics by females) and decreased reproductive 
success in some marine gastropods were causally linked to the exposure to tributyltin 
(TBT) [12]. A spill of organochlorine pesticides in Lake Apopka, Florida, USA, was 
assumed to be responsible for morphological abnormalities and impaired reproduction 
in the alligator population of the lake [13;14]. 
The term endocrine disruption has only be in use since the early nineties [15], although 
it is very likely that this type of effect has been occurring in wildlife at least as long as 
humans have been releasing synthetic chemicals into the environment [16]. The most 
widely used definition of endocrine disruption was agreed upon at the European 
workshop on the impact of endocrine disrupters on human health and wildlife, held at 
Weybridge, UK, in 1996 [17] as follows:  
An endocrine disrupter is an exogenous substance that causes 
adverse health effects in an intact organism, or its progeny, 
secondary to changes in endocrine function.  
This definition implies that an endocrine disrupter can be identified only when using in 
vivo test systems because it explicitly refers to adverse health effects in intact 
organisms. The term potential endocrine disrupter should hence be applied to 
compounds for which only in vitro endocrine activity was demonstrated. This term was 
also defined at the Weybridge workshop as follows:  
A potential endocrine disrupter is a substance that possesses 
properties that might be expected to lead to endocrine disruption in 
an intact organism. 
From these broad definitions it becomes evident that there is a large range of possible 
effects and mechanisms of action. Endocrine disrupters are believed to interfere with the 
functioning of hormone systems in at least three possible ways [18]:  
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By mimicking the action of a natural hormone such as estradiol or 
testosterone, and thereby setting off similar biological response in the 
body (e.g. via receptor activation) 
• 
• 
• 
• 
• 
• 
By blocking hormone receptors, thereby preventing the action of natural 
hormones (receptor antagonist) 
By affecting the synthesis, transport, metabolism and excretion of 
hormones, thus altering the concentrations of natural hormones 
 
Environmental risk characterisation of chemicals relies on results of toxicity tests with 
organisms representing several trophic levels. This approach can fail in detecting 
endocrine disrupting effects, since they often occur even at very low concentrations, 
much below the acute toxic concentrations of the studied compound. The capability of 
currently available test methods to detect effects related to endocrine disruption has 
been questioned [19] and the Scientific Committee on Toxicity, Ecotoxicity and the 
Environment of the European Commission has recognised the need for developing 
further tests on aquatic invertebrates to address properly endocrine disruption [20].  
While a substantial amount of research and method development has been conducted 
with respect to effects of EDCs in vertebrates, e.g. fish, relative little work has been 
carried out on aquatic invertebrates so far. 
Some hormones are believed to be unique to certain phyla of invertebrates. Examples 
are ecdysteroids, which regulate molting in insects and crustaceans and the juvenile 
hormones, which control metamorphosis in insects and are assumed to have similar 
function in crustaceans [21]. This together with the evidence that several crustaceans 
have hormones in common with vertebrates, so-called vertebrate-type steroid hormones 
– although their functional roles are unknown – make them suitable species for 
laboratory testing of potential endocrine disrupters. Moreover, the following criteria 
should be taken into account when selecting a certain invertebrate species for 
developing toxicity tests to study the effects of potential EDCs [22]: 
Primary mode of reproduction  
Relative sensitive to a range of chemicals of concern 
Easily to culture and to handle under laboratory conditions  
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Short generation time • 
• 
• 
• 
Size of organism 
Knowledge of basic endocrinology 
Availability of standard tests protocols, e.g. for acute toxicity testing 
 
Unfortunately, no crustacean species meets all the listed criteria; in particular, our 
knowledge on the endocrine system of crustaceans is still very limited. Even though, 
copepods seem to be very promising candidate test species in this context. This was 
reflected in the OECD Test Guidelines Program [23] in which highest priority has given 
to the development of survival and reproduction tests with crustaceans including 
marine, estuarine and brackish copepod species, e.g. Acartia tonsa and Tisbe battagliai. 
In this Ph.D. study, natural and synthetic hormones as well as a wide range of known or 
suspected EDCs were investigated for their sublethal effects on marine copepod species, 
the calanoid copepod Acartia tonsa and the harpacticoid copepod Nitocra spinipes. The 
main objectives of the work were: 
(1) Development and evaluation of a fully synthetic saltwater medium suitable for 
laboratory culturing of marine copepods including their feeding organism as well as 
for toxicity testing  
A synthetic media is always to prefer to a natural one in order to exclude as far as 
possible any contamination, which might interfere with investigated endpoints. This is 
of great importance when testing effects of potential EDCs and often not taken into 
account.  
(2) Identification of sensitive endpoints related to growth, development and 
reproduction of the pelagic calanoid copepod A. tonsa 
Ecdysteroids similar to vertebrate steroid hormones play a major role in the control of 
growth, development and reproduction in crustaceans. Therefore, these processes might 
be vulnerable to endocrine disrupters. Consequently, test systems were set up allowing 
studying various endpoints such as larval development ratio, sex ratio and egg 
production. Exposure experiments were conducted with naturally occurring and 
synthetic vertebrate and invertebrate hormones as well as compounds known to act as 
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endocrine disrupters in vertebrates in vitro or in vivo. Moreover, the study focussed 
particularly on the identification of endpoints suitable for screening purposes. 
(3) Applicability of the identified endpoint(s) for testing sublethal effects of model 
compounds 
Two groups of model compounds were chosen, brominated flame retardants (BFR) and 
synthetic musks. Both groups of substances are characterised by their ability to induce 
various specific toxic effects including endocrine disruption in vertebrates [24-26]. 
Furthermore, data on their ecotoxicity are scare. Effects of the model compounds on 
larval development ratio were studied in a partial life cycle test with A. tonsa lasting 
five days.  
(4) Comparative study with a second species, the benthic harpacticoid copepod Nitocra 
spinipes, using the same model compounds 
The BFRs and synthetic musks were investigated in a full life-cycle test with 
N. spinipes lasting three weeks. One of the endpoints was the larval development ratio, 
which directly could be compared with the results obtained in the A. tonsa tests.  
(5) Supplementary investigation of model compounds in an ecdysteroid sensitive in vitro 
test 
Results of in vivo methods can give an indication of a certain toxic mode of action of 
the investigated compound, which can be verified by the results of in vitro methods. 
Therefore, the model compounds were studied in vitro for ecdysteroid 
agonistic/antagonistic activity with the ecdysteroid-responsive Drosophila 
melanogaster BII cell line, in addition. 
(6) Proposal for a new OECD draft guideline using A. tonsa  
Though the majority of crustacean species rely entirely on sexual reproduction for their 
recruitment, the most often applied international guideline to test for effects on 
crustacean reproduction to date is based on parthenogenesis in Daphnia [27]. 
Standardised methods for testing chronic toxicity with sexually reproducing species are 
urgently needed, particularly for the evaluation of endocrine disrupting compounds. 
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2 The Endocrine Regulation of Crustacean 
Development and Reproduction 
2.1 Overview of Crustacean Endocrinology 
The use of hormones to regulate biological processes is a strategy common to 
vertebrates and invertebrates. Most of the current knowledge of crustacean 
endocrinology is obtained from studies with larger decapods such as crabs, lobsters, 
crayfish, and shrimps, and has been reviewed previously [21;28]. The endocrine 
mechanisms in crustaceans are, however, not very well understood. Basically, 
environmental stimuli are integrated by the central nervous system; neurotransmitters 
and neuromodulaters trigger the release of neuropeptides, which in turn control the 
synthesis of hormones by the endocrine glands. The use of hormone cascades with 
negative and positive feedback loops to regulate physiological processes is a successful 
strategy that has been appreciably conserved during evolution [28]. Such endocrine 
cascades provide a link between the nervous system and the endocrine system. They are 
also important for balancing actions of different hormones at multiple sites.  
In crustaceans, at least four major classes of hormones - steroids, terpenoids, peptides, 
and amines - are involved in the regulation of sexual differentiation, development, 
growth, molting, reproduction, and behaviour by a highly complex endocrine system. 
Other processes like carbohydrate metabolism, colour changes, pigmentation, limb 
regeneration, osmoregulation, and diapause, are under hormonal control as well. 
 
Figure 1 Lateral view of a generalised malacostracan showing the primary endocrine 
centres of crustaceans (modified from [29])  
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Table 1 Selected examples of hormones reported to be involved in development and 
reproduction of crustaceans, chemical types, sources, and functions  
Reported hormone Chemical type Source Function/controlled process 
Ecdysone  Steroid Y organs and gonads Molting, vitellogenesis 
Vitellogenesis stimulating 
ovarian hormone (VSOH) 
Steroid (?) Ovar Vitellogenesis, female secondary 
sexual characteristics 
Estradiol, testosterone, 
progesterone 
Vertebrate-
type steroids 
(unclear) (Functional role under debate) 
Methyl farnesoate (MF) Terpenoid Mandibular organ Metamorphosis, reproduction, 
stimulation of molting 
Molt-inhibiting hormone 
(MIH) 
Peptide X-organ/sinus gland Ecdysteroid synthesis 
Gonad- (vitellogenesis-) 
inhibiting hormone (GIH 
or VIH)  
Peptide X-organ/sinus gland Vitellogenesis 
Gonad-stimulating 
hormone (GSH) 
Peptide Protocerebrum Female and male reproduction 
Mandibular organ-
inhibiting hormone 
(MOIH) 
Peptide X-organ/sinus gland Molting, growth and reproduction 
Crustacean hyperglycemic 
hormone (CHH) 
Peptide X-organ/sinus gland Energy metabolism, inhibition of 
molting  
Androgenic gland 
hormone (AGH) 
Protein Androgenic gland Sexual differentiation 
 
Four hormone-producing sites are of special importance in crustaceans: 
The X-organ/sinus gland complex constitutes the major endocrine control centre and 
is located in the eyestalk of most higher crustaceans, indicating a close link to extern 
stimuli, e.g. photoperiod and light intensity. It serves as a storage and release site for 
several peptide hormones, e.g. molt-inhibiting hormone (MIH), gonad-inhibiting 
hormone (GIH), crustacean hypoglycemic hormone (CHH) and pigmentary 
hormones. 
• 
• 
• 
The Y-organs are paired and located in the maxillary segments. These glands are the 
source of the molting hormone ecdysone.  
The androgenic gland produces the androgenic gland hormone (AGH) responsible 
for sexual differentiation and male secondary sexual characteristics. The androgenic 
gland is lacking in females, where the ovary secrets the ovarian hormone, which 
induces differentiation of the female secondary sexual characteristics.  
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The mandibular organ releases methyl farnesoate (MF), a terpenoid similar to the 
juvenile-hormones known from insects, which stimulates the Y-organ and possibly 
also vitellogenesis.  
• 
Figure 1 illustrates the main endocrine centres in crustaceans. Unfortunately, endocrine 
glands or sites of hormone production in copepods are largely unknown. Table 1 
summarises sources and functions of hormones reported in crustaceans. 
2.2 Endocrine Regulation of Molting 
Crustaceans have to shed their exoskeleton (ecdysis, molting) in order to grow. Levels 
of the molting hormone 20-hydroxyecdysone fluctuate considerably during the molt 
cycle, which has four basic stages [29]: 
1. Postecdysis 
Expansion and hardening of the new exoskeleton, low ecdysteroid 
hemolymph level  
2. Metecdysis (Intermolt) 
Tissue growth, storage of food reserves, reproduction (if sexual maturity 
is reached), low ecdysteroid hemolymph level  
3. Proecdysis 
Preparation for shedding of old exoskeleton, increase in ecdysteroid 
hemolymph levels reaching a peak followed by a drastic decrease 
immediately prior ecdysis  
4. Ecdysis 
Uptake of water and shedding of old exoskeleton, low ecdysteroid 
hemolymph level  
 
Ecdysone, the crustacean molting hormone, was first isolated and characterised in the 
lobster Jasus lalandei [30]. The Y-organ primarily produces ecdysone, which, after 
release to the hemolymph, is rapidly hydroxylated to 20-hydroxyecdysone, the active 
ecdysteroid in most crustaceans. Moreover, the Y-organ also secretes two other 
ecdysteroids, i.e. 3-dehydroecdysone and 25-deoxyecdysone, with the latter forming the 
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precursor of the active ponasterone A (PoA) [31], their role remains to be determined 
(reviewed in [32]). PoA is the primary circulating ecdysteroid in the premolt stage of 
the crabs [31]. Advanced analytical techniques, e.g. ELISA, made it possible to quantify 
ecdysteroid levels also in smaller crustacean species.  
For example, changes in 20-HE concentrations through various life-stages of the 
harpacticoid copepod, Amphiascus tenuiremis, and the estuarine amphipod, 
Leptocheirus plumulosus, have been studied recently [33]. In active juveniles of the 
oceanic copepod Calanus pacificus, the variation in ecdysteroid levels relative to the 
molt cycle phase was similar to that known from decapod crustacean larvae. 
Ecdysteroid levels measured in field-collected juveniles in diapause (spontaneous state 
of dormancy) were lower than those in active juveniles [34]. 
The ecdysone secretion by the Y-organ is under negative control of the molt-inhibiting 
hormone (MIH), a neuropeptide released from the X-organ/sinus gland (Figure 2). The 
removal of eyestalks of the fiddler crab, Uca pugilator, induced a shortening of the molt 
cycle. This observation made already in 1905 (cited in [28]) was likely a result of a 
rapid elevation in the concentration of circulating ecdysteroids due to fact that the 
Y-organ was not any longer inhibited by MIH. Evidence for the ability of the 
X-organ/sinus gland to inhibit ecdysteroid secretion by the Y-organ was provided later 
[35;36]. In vitro secretion of ecdysone by crab Y-organs was inhibited when the organs 
were cultured with conditioned medium that had previously been incubated with 
explanted sinus glands. The neurotransmitter mediating the release of MIH from the 
sinus gland is serotonin [35]. In decapods, another neuropeptide with a structure very 
similar to that of MIH, the crustacean hyperglycemic hormone (CHH), does also inhibit 
ecdysteroid synthesis [37]. 
Besides this inhibitory regulation, the Y-organ is under positive control as well. 
Ecdysone levels in Y-organs cultivated in vitro together with mandibular organs were 
significantly higher compared to those cultured alone. The responsible factor was 
identified to be a terpenoid produced by the mandibular organ, methyl farnesoate (MF), 
which is the non-epoxidised form of juvenile hormone-III known from insects 
(reviewed in [38]). MF stimulates the secretion of ecdysteroids by the Y-organ in 
particular at the beginning of the proecdysis [39].  
In many crustaceans, the overall pattern of growth involves series of instars of similar 
morphology, followed by a specific molt resulting in substantial morphological 
changes. For example, in copepods, the sixth molt is linked to a change from the larval 
to the juvenile morphology. In insects, juvenile hormones control metamorphosis. Their 
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analogue in crustaceans, MF, is generally believed to play a similar role, but final 
evidence has not yet provided [37;38]. 
The synthesis of MF by the mandibular organ is in turn under negative control by 
another neuropeptid hormone, the mandibular organ-inhibiting hormone (MOIH). This 
was demonstrated in several studies. The addition of spider crab, Libinia emarginata, 
sinus gland extracts to cultured mandibular organs caused a significant decline in 
secreted MF in vitro [40]. Injection of sinus gland extracts in lobsters, Homarus 
americanus, induced a decline in circulating MF in vivo (reviewed in [28]). Subsequent 
work on this topic resulted in the characterisation and sequencing of MOIH [41;42].  
As already mentioned, most of the work elucidating the endocrine control of molting 
was performed with higher crustaceans, often by eyestalk ablation experiments. How 
the fluctuation of ecdysteroid levels during molt cycle is regulated in lower crustaceans, 
which do not have any eyestalk, is still unknown. 
Protocerebrum
CNSX-organ/
sinus glandY-organ
Ecdysone 
Mandibular
organ
MF  
Molt 
cycle MIH 
MOIH 
Figure 2 Endocrine control of molting in higher crustaceans (simplified scheme). 
Solid lines indicate stimulation; dashed lines indicate inhibition. CNS: 
central nervous system, MOIH: mandibular organ-inhibiting hormone, MIH: 
molt-inhibiting hormone, MF: methyl farnesoate 
 
2.3 Endocrine Regulation of Sexual Differentiation 
Although sex is determined genetically in most crustaceans, many aspects of 
reproduction, including maturation, maintenance and operation of the gonads, as well as 
development of secondary sexual characteristics are hormonally regulated [29] 
(Figure 3). Sexual differentiation in malacostracan crustaceans (e.g. decapods, isopods, 
amphipods) depends on the presence or absence of a certain protein produced in the 
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androgenic gland, which is typically associated with the terminal region of the male 
gamete ducts. This protein, the androgenic gland hormone (AGH) induces male 
morphogenesis, development of testis and secondary male sexual characteristics. In 
females, the primordial androgenic gland does not develop and the ovaries auto-
differentiate spontaneously, i.e. in the absence of AGH [43]. 
The role of the androgenic gland for sexual differentiation was elucidated in ablation 
and implantation experiments. In male prawns, Macrobrachium rosenbergii, the 
ablation of the androgenic gland induced feminisation including the initiation of 
oogenesis and development of oviducts and female gonopores [44]. Re-implantation of 
the androgenic gland revoked these effects. In penaed shrimps, Penaeus indicus, and 
isopods, Armadillidum vulgare, ablation of the androgenic gland caused 
demasculinisation [45]. On the other hand, the implantation of the androgenic gland into 
females caused masculinisation in M. rosenbergii [46] and functional sex reversal in 
A. vulgare [47]. 
2.4 Endocrine Regulation of Reproduction 
The endocrine control of crustacean reproduction has been investigated in a wide 
variety of species (for reviews see [21;28]). In males, peptide hormones are involved in 
the maintenance of the germinative tract via the regulation of the activity of the 
androgenic gland. A stimulating neurohormone was isolated from the brain and thoracic 
ganglia, the gonad-stimulating hormone (GSH). The X-organ/sinus gland is the source 
of the gonad-inhibiting hormone (GIH), which was demonstrated by eyestalk removal 
in immature crabs resulting in precocious gonad development [21].  
The hormonal regulation of female reproduction has been reviewed in detail [48]. The 
synthesis of vitellogenin, the precursor of vitellin, the major yolk protein of mature 
crustacean eggs, is under subtle hormonal control. Several tissues, e.g. the ovary, 
hepatopancreas and subepidermal adipose tissue have been postulated as the sites of 
vitellogenesis [49]. GSH has a stimulatory effect, whereas GIH inhibits the synthesis of 
vitellogenin and its uptake by the fat body. The latter is therefore also called 
vitellogenesis-inhibiting hormone (VIH) [43;48]. In some amphipods, vitellogenesis is 
under positive control of the vitellogenin-stimulating ovarian hormone (VSOH), which 
seems to play a similar role as 17β-estradiol in egg laying vertebrates [43]. In an isopod, 
A. vulgare, vitellogenesis was shown to be under negative control of AGH by ablation 
of the androgenic gland from males, which initiated synthesis of vitellogenin by the fat 
body, whereas, implantation of the androgenic gland to females inhibited vitellogenin  
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Figure 3 Endocrine control of sexual differentiation and reproduction in a female (A) and a 
male (B) crustacean (simplified scheme). Solid lines indicate stimulation; dashed 
lines indicate inhibition. CNS: central nervous system, MOIH: mandibular organ-
inhibiting hormone, GIH: gonad-inhibiting hormone, GSH: gonad-stimulating 
hormone; MF: methyl farnesoate, AGH: androgenic gland hormone, VSOH: 
vitellogenesis-stimulating ovarian hormone, OH: ovarian hormone 
synthesis [50]. Thus, vitellogenesis in crustaceans is under negative regulatory control 
by an androgen, whereas in oviparous vertebrates estradiol positively controls 
vitellogenesis.  
Elevated levels of MF found in the hemolymph of vitellogenic females as well as 
reproductively active males revealed that also this hormone is important for 
reproduction [51]. MF stimulates ovarian maturation in crayfish [52]. However, the 
specific role of MF in crustacean reproduction is unclear [28]. Several studies with 
higher crustaceans indicated, that also ecdysteroids are involved in reproduction, 
vitellogenesis, and embryogenesis (reviewed in [31]). Recently, this was also shown for 
lower crustaceans, e.g. copepods and amphipods [33]. However, the specific function of 
ecdysteroids for reproduction remains to be determined and may vary among taxa [28].  
Because of the complexity of vitellogenesis and the general shortage of fundamental 
knowledge of crustacean endocrinology, the induction of vitellogenin has not been used 
as a biomarker of endocrine disruption to the same extent as the up-regulation of this 
egg yolk protein in fish [53]. However, a few studies reported induction of vitellin or 
vitellin-like proteins after exposure to estrogenic compounds in grass shrimps, 
Palaemonetes pugio [54] and barnacles, Balanus amphititre [55]. Very recently, vitellin 
from an estuarine mysid, Neomysis integer, was purified and characterised as a first step 
to develop immunoassays to study vitellogenesis in mysids [56]. Volz and Chandler 
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[57] developed an ELISA capable of detecting vitellogenin in copepods and other 
crustaceans at concentrations as low as 2 ng/ml, which may be applied in evaluating 
endocrine activity of environmental toxicants.  
2.5 Vertebrate-Type Steroid Hormones 
In Crustaceans, estradiol and estrone were identified in 1978 by Jeng et al. [58]. 
Subsequent studies demonstrated the presence of these hormones and progesterone in 
the ovary, hepatopancreas and the hemolymph [59-62]. Testosterone has been isolated 
from and identified in serum and testes of lobsters [63]. For more detailed information 
on the presence of vertebrate-type hormones including steroids in crustaceans see the 
review by Fingerman et al. [64]. Several studies revealed a notable capability of 
crustaceans, e.g. the cladoceran Daphnia magna and mysid shrimps, to metabolise 
testosterone [65-68]. Recently, we provided first evidence for the existence of a specific 
testosterone binding-site in cytosolic extracts of whole body homogenates of the 
amphipod Hyalella azteca using a radio-receptor assay (Lutz and Wollenberger, 
unpublished data). Altogether, there are strong indications that vertebrate-type steroids 
may function as hormones in crustaceans, however, their precise physiological role and 
mechanisms of action remain to be elucidated. 
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3 Materials and Methods 
3.1 Selection of Test Species  
In the initial phase of this project, the chronic toxicity of antibiotics towards crustaceans 
was investigated [1] using the well-established Daphnia magna reproduction test [27]. 
During the course of the project, special emphasis was put on potential EDCs. 
Numerous studies describe effects of EDCs like alkylphenols, phthalates and vertebrate 
steroid hormones on D. magna, e.g. [69-73]. Like many other cladocerans, daphnids are 
parthogenetic under favourable environmental conditions. In some of those studies, a 
switch to sexual reproduction was induced by for example reduction in food supply, 
high population density [74] or shortening of the photoperiod [75]. This implies the 
exposure of test animals under sub-optimal conditions and might therefore influence 
their sensitivity towards toxic stress and thus impact test results. Neither working with 
an asexually reproducing organism nor exposure of D. magna under sub-optimal 
conditions to prevent parthogenesis were considered an appropriate approach for 
developing a test for detecting sublethal effects of potential endocrine disrupters. Hence, 
it was decided to look for small crustaceans with sexual reproduction as alternatives of 
D. magna. The calanoid copepod Acartia tonsa and the harpacticoid copepod Nitocra 
spinipes were selected, their cultivation in the laboratory optimised and sensitive 
sublethal endpoints that may be responsive to EDCs identified in sublethal toxicity tests 
with these species.  
3.2 Development of a Fully Defined Marine Medium  
To my knowledge, no fully defined marine medium developed specifically for 
cultivation of A. tonsa and the organism it feeds on, the cryptophycean alga 
Rhodomonas salina, and toxicity testing was available when I had started my Ph.D. 
work. In particular, when working with potential endocrine disrupters, which can affect 
organisms at extremely low concentrations, it is of greatest importance to avoid any 
contamination of the medium, which might confound the test results. By now, mainly 
natural seawater was used for toxicity testing with marine crustaceans, whose 
composition can vary from laboratory to laboratory or day to day in respect to the site 
and time of sampling. Consequently, contamination with chemicals that might 
contribute to the overall effect observed in the toxicity test could neither be excluded 
nor quantified. Thus, there was a need for a fully defined marine medium suitable for 
cultivation of the test organism, its food as well for performing toxicity tests.  
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In this study, a fully defined media was developed allowing the cultivation of A. tonsa 
and R. salina without problems for eight month [2]. Meanwhile this medium has been in 
use for more than five years in our laboratory and was successfully applied in various 
studies [3;4;6]. Moreover, this newly developed medium should be considered for 
cultivation of other marine organisms.  
To check the sensitivity of A. tonsa towards chemicals when cultivated in the new 
medium, 48-h acute toxicity tests according to ISO 14669 [76] were performed with 
bisphenol A, nonylphenol and the two reference compounds, 3,5 DCP and potassium 
dichromate. The determined LC50 of 16 mg/l for potassium dichromate and the 
corresponding 95% confidence interval of 13 to 21 mg/l were in-line with results of a 
previous interlaboratory comparison [2]. The advantage of using fully defined marine 
media was also recognised by the OECD working group in the revised version of the 
proposal for a new OECD Draft Guideline for Testing of Chemicals - Calanoid 
Copepod Development and Reproduction Test with Acartia tonsa [8].  
3.3 Copepods  
3.3.1 Overview of Copepod Biology 
The Copepoda form a subclass of the class Crustacea. Approximately 12,000 copepod 
species have been described until 1993 [29]. Calanoida and Harpacticoida are two out 
of ten copepod orders. The name copepod originates from the Greek words kope (oar) 
and podos (foot), and refers to the flat, laminar swimming legs of the animals [77]. 
Copepods are microscopic, primarily marine animals and represent important prey items 
for larvae of many fish and larger invertebrates and are increasingly used as a live food 
source in aquaculture.  
Copepods are sexually dimorphic; males are usually smaller than females. During 
copulation, the males transfer sperm to the females by placing a spermatophore close to 
the opening of the egg duct of the female. After mating, females can store the sperm and 
therefore, a single copulation enables females to produce fertilised eggs for a longer 
time, in some species throughout the entire reproductive period. In calanoids, eggs are 
released singly into the water, but in most other copepods, e.g. harpacticoids, eggs are 
deposited by the female in one or two egg sacs (ovisacs) and brooded until the nauplii 
hatch. During development, copepods pass through six naupliar and five copepodite 
stages before turning into adults. The copepodites have the adult shape, while the 
nauplii are less differentiated and almost circular. Newly hatched, the unsegmented first 
nauplius stage already possesses three pairs of appendages. At each successive molt, 
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these appendages develop further setae or segments. Moreover, rudimentary forms of 
other appendages and additional somites (body segments) develop during the nauplius 
stages. The first copepodite stage displays the general adult features, but the abdomen is 
still unsegmented. Segmentation of the abdomen takes place and limbs are formed with 
each subsequent molt. The adult copepod has got ten somites with six pairs of 
appendages [29].  
3.3.2 Acartia tonsa 
Acartia tonsa Dana belongs to the calanoid copepods, tolerates salinities between 10 
and 35 ‰ and is a very common species in Danish coastal waters. Species of the genus 
Acartia are widely distributed in brackish and coastal waters around the world and often 
dominating in the zooplankton. They feed on planktonic microalgea and are thus 
ecologically important links between primary producers and organisms of higher 
trophic levels in marine food webs.  
A detailed description of A. tonsa and a protocol for its cultivation are given in [8]. 
Depending on temperature (15 to 20 °C), A. tonsa reaches the adult stage after 9 to 20 
days [77]. In the laboratory under optimised conditions, a female can produce up to 60 
eggs per day, which hatch after 24 hours. The body length of females is about 1.0 mm, 
while that of males is only around 0.8 mm. Males and females are easily to distinguish 
from each other (Figure 4). A. tonsa has been used in ecotoxicological tests for many 
years [78]. An International Standard (ISO) for acute toxicity testing exists [76]. 
 
 
Figure 4 Main secondary sex characteristics of a generalised calanoid copepod (the 
specification of size is related to Acartia tonsa) 
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3.3.3 Nitocra spinipes 
Nitocra spinipes Boeck is a deposit-feeding harpacticoid copepod, which is a common 
component of the benthic meiofauna in shallow coastal waters of many regions around 
the world. It tolerates salinities between 0 and 35 ‰. Females have a body length of 
about 0.75 mm and are generally bigger than males (0.45-0.56 mm). At 22 °C, 
N. spinipes reaches sexual maturity within 10-12 days; the generation time is 16-18 d. 
Females develop single egg sacs (Figure 5) and can produce at least six broods during 
their life [79]. N. spinipes has been used in ecotoxicological tests since 1975 [80]. An 
International Standard (ISO) for acute toxicity testing exists [76]. 
 
 
Figure 5 Ovigerous Nitocra spinipes female (Drawing by Göte Göransson) 
 
3.4 Copepods as Test Species for (Sub)chronic Toxicity Testing 
General criteria for the selection of invertebrate species suitable for identifying toxic 
effects related to endocrine disruption in the environment were given by Ingersoll et al. 
[22] and include primary mode of reproduction, suitability for culturing in the 
laboratory, generation time, size of organism, knowledge on endocrinology, and 
availability of standard methods. The copepod species used in this study reproduce 
sexually and endpoints like fecundity or sex ratio are applicable. Laboratory cultures are 
well established and the short generation time allows conducting full life-cycle and 
trans-generational exposures. On the other hand, organisms with a short generation time 
are typically small. The size of an organism is important not only for practical reasons, 
e.g. required space, amount of food, but also for determining concentrations of 
hormones in the tissue. For instance, the dry weight of an adult A. tonsa individual is 
only 5 µg (this study, unpublished data). This implies that it would not be possible to 
get enough tissue for chemical analysis when working with A. tonsa and, therefore, the 
determination of hormone concentrations in tissue samples was excluded from the scope 
of this study from the first. Basic knowledge on the endocrine system of the test 
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organism is important for the identification of endpoints related to endocrine controlled 
processes, which can be expected to be susceptible towards endocrine disruption. 
Though our knowledge on crustacean endocrinology is limited, the crustacean and 
insect hormone systems are the best understood among invertebrate phyla and some 
information on the endocrine regulation of e.g. molting and reproduction is available 
(chapter 2).  
The characteristics and biological attributes given in Table 2 facilitate the measurement 
of survival, hatching success, larval development ratio, body length, sexual maturation, 
egg production, egg diameter and sex ratio. These endpoints can be categorised as 
follows: General toxicity (mortality), endpoints related to growth and molting as well as 
endpoints related to sexual differentiation and reproduction (Figure 6). 
 
Table 2 Fundamental characteristics of Acartia tonsa and Nitocra spinipes related to their 
suitability as test species in ecotoxicology 
Acartia tonsa Nitocra spinipes 
Pelagic 
Easily to culture under laboratory 
conditions  
Non-cannibalistic 
Sexual reproduction 
Continuous release of individual eggs 
(up to 60 per female and day) 
Nauplii and copepodites are easily to 
distinguish from each other 
Visual sex determination feasible  
Generation time 14 d (at 20 °C) 
Size 0.8-1.0 mm  
ISO Standard available for acute toxicity 
testing 
Benthic 
Easily to culture under laboratory 
conditions 
Non-cannibalistic 
Sexual reproduction 
Single egg sac 
  
Nauplii and copepodites are easily to 
distinguish from each other 
Visual sex determination feasible 
Generation time 17-20 d (at 20 °C) 
Size 0.45-0.75 mm  
ISO Standard available for acute toxicity 
testing 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
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Figure 6 Lethal and sublethal endpoints related to general toxicity, growth and development, 
and reproduction measurable in acute, subchronic and chronic toxicity tests using the 
calanoid copepod Acartia tonsa and the harpacticoid copepod Nitocra spinipes 
 
 
Lethal effects are studied in short-term ecotoxicity tests, where the exposure time is 
short compared to the generation time of the organism. Sublethal effects as for example 
inhibited larval development or decreased reproductive success, are studied in 
subchronic and chronic tests. In chronic toxicity tests, organisms are exposed a 
substantial period of their life cycle, while in subchronic tests, exposure time is in-
between that of acute and chronic tests. Full life-cycle tests cover all life stages, which 
may not be equally sensitive to a given compound. They can thus include embryo-larval 
stages as well as periods of gonad development and reproduction. Moreover, exposures 
can be extended over more than one generation to include some or all key life stages in 
the next generation (Figure 7). Since the sensitivity of certain developmental stages and 
critical periods of endocrine function often are not known, full life-cycle tests are 
considered the best way to study EDCs with regard to their environmental risk [22]. 
Full life-cycle test with various copepod species, for example Tisbe battagliai [81;82], 
have been used in a number of studies with EDCs. In the present study, selected model 
compounds (polybrominated diphenyl ethers and synthetic musks) were studied in a full 
life-cycle test with N. spinipes [5;7]. 
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Figur 7: Crucial developmental stages of crustaceans, which might be sensitive towards 
endocrine disrupters, in a life-cycle context. A partial life-cycle test covers a certain 
stage of development, whereas a full life-cycle test covers all stages of the F0 
generation and might be extended to some or all stages of the F1 generation in a trans-
generational exposure. The methods applied in this study are plotted in relation to the 
life-cycle of the test organism. (Modified from [22]) 
 
The primary objective of this dissertation was, however, the identification of sensitive 
endpoints applicable to screen chemicals for sublethal effects using A. tonsa. Such 
screening tests should be easily to perform, be accomplished within a reasonable 
timeframe and give a reliable indication of chronic toxicity of the tested compound. 
Hence, in this study endpoints like larval development ratio and egg production were 
investigated in detail in subchronic exposure experiments, so-called partial life-cycle 
tests, with A. tonsa. In a follow-up project, these endpoints were implemented in a 
trans-generational full life-cycle test covering the interval from hatching of the F0 
generation to the appearance of copepodites of the F1 generation [8]. 
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3.5 Endpoints Investigated in A. tonsa  
The methods applied including the experimental details are given in the papers included 
in the annex [2-8] and hence, summarised in the following only briefly. Adult acute 
toxicity tests were performed prior to subchronic and chronic testing of the chemicals in 
order to define the concentrations to be tested. Generally, the LC10 values obtained in 
the acute toxicity test were set the upper limit of the concentration range for the 
subchronic and chronic tests. N. spinipes 96-h acute toxicity tests as well as A. tonsa 
48-h acute toxicity tests were performed according to ISO 14669 [76].  
3.5.1 Larval Development Ratio 
Starting point for the larval development tests was a study published in 1997 in which 
the authors reported that the known endocrine-disrupting chemical TBT was a highly 
potent inhibitor of the development of A. tonsa larvae with an EC50 160 times lower 
than the LC50 value obtained in an acute toxicity test with adults. In contrast, linear 
alkylbenzene sulfonate, which is not associated with endocrine disruption, did not affect 
larval development at sublethal concentrations [78]. The development of copepods 
includes several molts and one metamorphosis from the nauplius to the copepodite 
morphology. Both processes, molting and metamorphosis, are regulated by 
ecdysteroids. Furthermore, the metamorphosis is presumably controlled by MF, similar 
the juvenile hormones regulating metamorphosis in insects (chapter 2). For this reason, 
it was studied, how far a test based on measuring the percentage of test animals that 
have turned from nauplii into copepodites in a certain time period, would be suitable to 
screen potential EDCs for (sub)chronic toxicity.  
The larval development test covers the period of development from hatching to the first 
copepodite stages (Figure 7 and 8). The easily detectable change from the nauplius to 
the copepodite morphology was utilised as endpoint. At the time, when about 50% of 
organisms in the control had reached a copepodite stage, which takes 5 days at 20 °C, 
the larval development ratio (LDR), expressed as the percentage of test organisms that 
have turned into copepodites (number of copepodites/[number of nauplii 
+ copepodites]), was recorded for each replicate of the treated groups and compared 
with that of the control. Choosing the time when attaining LDR = 50% in the control as 
time to determine LDR in the exposed groups enables the detection of both stimulation 
as well as inhibition of larval development. 
Experiments were started by adding a known number of eggs (30-40) produced by the 
copepod stock culture within a period of 24 h to 100 ml glass beakers containing 80 ml 
of working test solution. The test included six concentration levels in a geometric 
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concentration series. Twelve replicates were used for controls and four for each test 
concentration. The exposure was conducted at 20 ± 0.5 °C and under a light regime of 
16 h light to 8 h dark and semi-static conditions with feeding of micro-algae (R. salina). 
To ensure that the experiments were finished when the LDR in the control was 
approximately 50%, the number of nauplii and copepodites was determined in one 
control replicate after exactly 5 days. If this control contained less than 50% 
copepodites, the test was allowed to run for another hour, after which an additional 
control replicate was studied, etc. At the end of the test, unhatched eggs, nauplii and 
copepodites were counted in all replicates. EC values for the inhibition of the LDR were 
calculated. Additionally, hatching success and larval mortality were recorded.  
It is worth noting that a constant temperature is essential in conducting the larval 
development test, in particular it is absolutely necessary to prevent any temperature 
gradient between the individual beakers used in the test. Minor deviations in 
temperature delay or accelerate larval development significantly (unpublished data).  
In the course of this study, inhibition of the development of A. tonsa larvae has proven 
to be the best suitable parameter for screening purposes. Larval development tests were 
performed with in total 38 compounds, including natural vertebrate and invertebrate 
hormones, synthetic hormones, industrial chemicals, pesticides, brominated flame 
retardants, synthetic musks and a set of reference compounds (Table 3).  
3.5.2 Sex Ratio 
In preliminary experiments, the parameter sex ratio (number of females divided by the 
total number of animals) was investigated. Animals were exposed during the period of 
development from egg to adults under the same temperature and light conditions as 
described above for the larval development test. The exposure lasted 12 to 14 days. The 
sex ratio in the controls varied between about 0.5 and 0.8. Due to the high variability in 
the sex ratios seen in control groups and the rather time-consuming and labour-intensive 
method, sex ratio was not considered further a suitable endpoint for screening purposes. 
However, for the time being it is envisaged one of the endpoints in the full life-cycle 
test with A. tonsa [8]. 
3.5.3 Egg Production  
Some copepods like A. tonsa produce eggs continuously from sexual maturation to the 
end of their life span. Since A. tonsa releases eggs one by one to the water, it is 
relatively easy to count the number of eggs released per female during a certain period 
of time and use this parameter as a reproductive endpoint. From previous studies with 
A. tonsa it was noted that egg production during the first three days of sexual maturity 
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rises to a constant level, which is the production capacity of the animals with the 
available food resources [83]. Under the laboratory conditions chosen in the present 
study, egg production started when the copepods were about 10 days old. The number 
of eggs produced per female within 24 h was counted from day 14 to 15 and again from 
day 16 to 17, i.e. during the period of maximum egg production capacity. 
Test organisms aged 11 days were exposed for 6 days and the number of eggs produced 
per female during a period of 24 h was determined on day 4 and 6. Thus, prior to 
measuring egg production the animals were pre-exposed for 72 and 120 h, respectively. 
A geometric series comprising six different concentrations with 4 replicates per 
concentration was tested. Each replicate contained 80 ml of test medium and 10 
animals, which were sexed after completion of the test on day 17 in order to determine 
the number of females present in the respective replicate. Sex determination was carried 
out at the end of the test since it was impossible to sex living A. tonsa without stressing 
or damaging them. The exposure was conducted under semi-static conditions, at 20 ± 
0.5 °C with a 16 h light to 8 h dark rhythm. Organisms were fed with micro-algae 
(R. salina). The test vessels consist of 100 ml beakers with an inner chamber that holds 
the test animals. The bottom of this chamber is made of a stainless steel sieve of 180 µm 
mesh size. A. tonsa eggs have an average diameter of 80 µm (unpublished data) and can 
thus pass the sieve and sink to the bottom of the beaker. After the observation period of 
24 h, the inner chambers containing the animals were carefully transferred to other 
beakers containing fresh test solution and the remaining eggs were counted. The number 
of eggs produced per female of the exposed groups was compared to those of the 
control groups and effect concentrations (ECX, LOEC, NOEC) determined.  
 
 
 
Figure 8 Endpoints related to development and reproduction recorded in the larval 
development and the egg production test with the calanoid copepod Acartia tonsa 
(above the line); approximate age in days and crucial events in the life-cycle (below 
the line) 
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3.6 Full Life-Cycle Test with N. spinipes  
The work with N. spinipes was performed in close co-operation with Magnus Breitholtz 
at the Institute of Applied Environmental Research (ITM), Stockholm University, 
Sweden. The full life-cycle test with N. spinipes is described in detail in [5;7]. Nauplii 
less than 36 hours old were randomly allocated to vials containing 5 ml of brackish 
water. Each vial, with 10-15 nauplii, was then randomly allocated to groups, of which 
each comprises 8 replicates. Thereafter, 5 ml of a test solution containing the chemical 
to be studied in a certain concentration were added to the vials belonging to a particular 
group. Every second day, copepods were fed with a feed suspension prepared from 
commercial salmon feed as well as 70% of the test solutions renewed. On day 6-8, the 
first endpoint, the LDR, was recorded as the percentage of copepodites among all 
offspring divided by the total number of juveniles at the beginning of the experiment. At 
this time about 50% of the individuals had normally reached the copepodite stage. 
Mortality rates were determined by counting the living organisms on day 6-8. On day 
15-18, ovigerous females started to appear and were then individually transferred to 
vials containing fresh test solution. The exposures were generally terminated on day 18. 
However, individually isolated ovigerous copepods were left in exposure to hatch their 
eggs for additional four days. Released nauplii and aborted egg sacs were counted. 
Remaining copepods were fixed in formaldehyde (4%), sexed and examined for 
morphological malformations. If the average control mortality plus handling losses 
exceeded 20% on day 6-8 or 30% on day 18-22, the experiments were considered not 
valid. Figure 9 shows the endpoints, which are related to larval development, i.e. LDR, 
as well as to later developmental stages and reproduction, i.e. mortality rate, time to 
release of first brood, sex ratio, the fraction of ovigerous females among all females and 
the number of nauplii per ovigerous female. A modified Euler-Lotka equation [5] was 
used to calculate a population level endpoint, the intrinsic rate of natural increase (rm) 
from these individual life-table endpoints.  
3.7  Ecdysteroid Receptor-Based in vitro Screening Assay  
The work with the Drosophila malanogaster BII cell in vitro assay was performed in 
close co-operation with Laurence Dinan at the Department of Biological Sciences, 
University of Exeter, U.K. The BII test was developed by Clement and Dinan in 1993 
[84] and is described in [5;6]. The assay was performed with four synthetic musks [5], 
six brominated flame retardants [6] as well as vinclozolin and fenoxycarb (this study, 
unpublished data).  
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 Figure 9  Endpoints related to development, reproduction and population growth recorded 
in the full life-cycle test with the harpacticoid copepod Nitocra spinipes (above the 
line). Approximate age in days at crucial events in the life-cycle test (below 
the line)  
 
The BII screening assay for detection of ecdysteroid agonists and antagonists is ideally 
suited to the evaluation of environmental contaminants as potential EDCs [85] and 
proven to be reliable, simple and robust [86]. The BII bioassay is based on the 
ecdysteroid response of the Drosophila malanogaster BII cell-line [84]. The bioassay is 
performed by growing the cells in the wells of microtitre plates and the response can be 
measured turbidimetrically. In the presence of 20-HE or a compound with ecdysteroid 
agonist activity, these cells form phagocytotic clumps with concomitant increase in cell 
size and reduction in cell density. The assay is sensitive, giving a full agonist response 
with 5 ng 20-HE equivalents per well and a detectable response with 0.5 ng 20-HE 
equivalents [86]. By addition of a known amount of 20-HE per well, the test can be 
modified to test for the presence of ecdysteroid receptor antagonists.  
When testing for endocrine disruption in vivo, it is important to remember that many 
effects on endocrine regulated processes can occur via other specific mechanisms or due 
to general toxicity. As a complementary method to in vivo studies, the BII assay can 
contribute to a better understanding of the mechanisms behind effects observed in in 
vivo tests. 
3.8 Acute-to-Chronic Ratios 
Another approach to distinguish effects caused by specific modes of toxic action from 
those related to general toxicity is the acute-to-chronic ratio (ACR). The ACR is defined 
as the ratio of a chemicals acute toxicity expressed as e.g. LC50 and its chronic toxicity 
expressed as e.g. LOEC or EC50 and varies strongly depending on the mode of action 
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[87]. The ACR is typically below 10 for pure baseline toxicants and can be much higher 
if the mode of toxic action in the chronic test is different from that in the acute test [88]. 
It is important to note that only ACR values based on the same chronic toxicity 
parameter (e.g. either LOEC or EC50) may be compared and hence, published data 
should be interpreted with care taking this fundamental assumption into account. In risk 
assessment, a factor of 10 is often used to extrapolate from acute effect concentrations 
to chronic effect values [89]. Thus, this factor is assumed to reflect differences between 
acute and chronic toxicity values. In this study, an ACR exceeding 10 was therefore 
considered as indication for a specific mode of toxic action. ACRs were calculated 
using LC50 from adult acute toxicity test with A. tonsa and EC50 derived from the larval 
development test. ACRs derived from tests with N. spinipes were calculated using LC50 
from acute toxicity test and LOEC from full life-cycle tests. This implies that ACRs 
derived from A. tonsa tests and N. spinipes tests cannot readily be compared. 
3.9 Test Compounds 
Tabel 3 provides an overview of the compounds investigated in this study, their known 
endocrine effects as well as the applied test methods.  
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4 Effects of Potential Endocrine Disrupters on 
Crustaceans 
4.1 Introduction 
Although endocrine disruption in invertebrates has not been studied as extensive as in 
vertebrates, in particular in fish, numerous reports on the effects of EDCs on 
crustaceans have been published since the beginning of the nineties, e.g. [66;90;91]. By 
far most of these investigations were laboratory studies but a few field studies do also 
exist [92;93]. The majority of early reports on endocrine effects in crustaceans dealt 
with compounds for which estrogenic or anti-estrogenic effects had already been 
detected in vertebrates, e.g. alkylphenols, BPA, phthalates, organochlorine pesticides 
and natural as well as synthetic hormones. The results of these investigations were in 
part inconsistent and showed that some crustacean groups may be affected by exposure 
to EDCs, but other may not and, therefore, extrapolation of results from one crustacean 
group to another is problematic. Effects of potential EDCs in crustaceans may be other 
than those anticipated by knowledge of their actions in vertebrates. It is known that 
some processes regulated by estrogens in vertebrates are controlled by androgens in 
crustaceans, e.g. sexual differentiation (chapter 2). Therefore, androgens and anti-
androgens were included in studies on endocrine disruption in invertebrates as well. 
Another frequently studied group of substances comprises compounds, which affect 
specifically the hormonal system of arthropods. To this group belong hormones unique 
in arthropods such as juvenile hormones and ecdysteroids as well as chemicals that have 
been purposely synthesised to disrupt the endocrine system of a number of insects to aid 
their control. These so-called insect growth regulators represent third generation 
insecticides and were developed to intentionally interact with the hormonal system of 
arthropods, acting as ecdysone agonists or antagonists or as juvenile hormone 
analogues. In most studies, existing ecotoxicological test protocols were applied 
sometimes modified or extended in order to investigate endpoints related to processes 
regulated by hormones as growth, molting, sexual maturation and offspring production. 
These endpoints were for example considered for developing life-cycle tests with 
copepods and mysid shrimps [5;7;82;94;95]. Only recently, efforts have been 
undertaken to develop new methods using endpoints like DNA-response, steroid 
hormone levels and steroid metabolism as biomarkers for endocrine disruption 
[57;67;96;97]. A few receptor binding assays are available such as the BII test for 
identification of compounds with (anti)ecdysteroid activity [86]. 
In this thesis, a comprehensive literature survey on endocrine disruption in crustaceans 
was conducted, which has been summarised in Table 4. In principle, endocrine 
 29
disruption in crustaceans cannot be considered irrespective of research on endocrine 
disruption in other invertebrates. In particular, studies on insects are of fundamental 
importance for the interpretation of the effects seen in crustaceans. Nevertheless, the 
information given in Table 4 was confined strictly to crustaceans. 
From the author’s point of view, the Table 4 summarises the results of the most relevant 
publications available by September 2004. It comprises about 100 studies, which were 
organised with reference to the organism groups and contains information on the 
compounds studied, the effects observed and the effective concentrations. From the 
large number of cited references it becomes obvious that it would be impossible to deal 
with all studies within the framework of this synopsis. That is why those interested in 
more detailed information are referred to recent reviews [22;98-101] but it should be 
noted that these reviews are not as complete and up-to-date as that given here. 
Many of the compounds studied by other authors were incorporated in the 
investigations conducted during this Ph.D. work (Table 3). The results of these 
experiments were discussed in detail in the publications enclosed in the annex, and 
hence, will not be repeated below. An overview of important so far unpublished results 
is given in Table 5. In the course of this study it has become apparent that the larval 
development ratio (LDR) was the most suitable endpoint for screening of potential 
EDCs. For this reason, the following discussion focuses primarily on literature referring 
to endpoints related to molting and development. 
4.2 Ecdysteroids, Juvenile Hormones and Insect Growth 
Regulators 
4.2.1 Ecdysteroids 
Ecdysteroids, the molting hormones in arthropods, are important as reference 
compounds for evaluating effects of xenobiotics on the molting process in crustaceans. 
Therefore, 20-HE has been recommended as a reference chemical when testing 
chemicals suspected to be ecdysone agonists [22]. Homobrassinolide, a steroid 
produced by several plants and some invertebrates to protect them against predators 
[102;103] was proposed as positive control for ecdysone antagonists [22]. To the best of 
my knowledge, no studies with homobrassinolide in relation to effects of potential 
EDCs on crustaceans have been published so far.  
Baldwin et al. [104] exposed D. magna in a life-cycle test lasting 21 days to two 
ecdysteroids, 20-HE and PoA. The latter is an ecdysteroid found in crustaceans and 
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many plants and has a tenfold higher affinity to the ecdysteroid receptor than 20-HE 
[86]. PoA was almost ten times more toxic to Daphnia magna than 20-HE, indicating 
that the toxicity was in fact related to the ecdysteroid receptor. Daphnids were 
monitored for alterations in molting, fecundity and survival time. While both 
compounds did not have appreciable reproductive effects on daphnids, the study 
revealed some useful indicators of ecdysteroid exposure, e.g. incomplete ecdysis 
(inability to complete exuviations of the molt) leading to premature death. Though this 
effect only occurred at relatively high concentrations, Baldwin et al. suggested that 
incomplete ecdysis could be used in chronic toxicity testing to indicate that a particular 
chemical or effluent affect ecdysteroid function. PoA and other steroids produced by 
plants are possibly constituents of pulp and paper mill effluents and therefore may 
represent an environmental threat to arthropods living in waters near such industries.  
20-HE was included as positive control for effects on molting in studies with several 
copepods species, e.g. Tisbe battagliai [105], Tigriopus japanicus [106], and A. tonsa 
[3] as well as in studies with D. magna [104;107-109]. While 20-HE significantly 
delayed molting in D. magna and also was toxic towards some copepods, no specific 
effects on naupliar development were seen in any of the three copepod species. NOECs 
for effects on naupliar development were 86.5 µg/l (T. battagliai), 10 µg/l 
(T. japanicus) and 1,500 µg/l (A. tonsa).  
Since rapid degradation of 20-HE in the test medium could be one reason for not 
observing any effects on A. tonsa larval development [3] the experiment was repeated 
renewing the test solutions daily. The tested concentration range was 0.075-1.5 mg/l. A 
weak but significant stimulation of larval development was observed at 0.9 and 
1.5 mg/l. This was the first observation of a stimulatory effect on larval development in 
my work with A. tonsa (this study, unpublished data). Taking into account that 20-HE 
is a naturally occurring hormone the determined effective concentrations seem to be 
rather high.  
The fact, that 20-HE had no effect on larval development of T. battagliai and 
T. japonicus [105;106] together with the observation that it stimulated larval 
development in A. tonsa only at rather high concentrations suggests 20-HE not being 
the active molting hormone in these copepod species. Moreover, in A. tonsa PoA was 
100 times more potent in stimulating LDR than 20-HE (see below), although its in vitro 
ecdysteroid activity is only ten times higher than that of 20-HE [86]. 
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In the present Ph.D. work, PoA was studied in two experiments with A. tonsa. In the 
first test, a range from 2 to 500 µg/l was investigated. At 2 µg/l a significant stimulation 
of the LDR (32 %) was observed, whereas higher concentrations seemed to be toxic, no 
larvae reached a copepodite stage at concentrations ≥ 55 µg/l. Thus, a lower 
concentration range (0.1-10 µg/l) was tested in the second experiment. A stimulation 
occurred at all concentrations, but was only significant at 0.64 µg/l (30 %) and at 
1.6 µg/l (41%) (this study, unpublished data). It would be interesting to utilise this 
stimulatory effect of a potent ecdysone receptor agonist in future mechanistic studies of 
suspected disrupters of the ecdysteroid system by a co-exposure with PoA. 
Since ecdysteroids act as major endocrine-signalling molecules in crustaceans and are 
not only involved in molting [28] it may be expected that a chemical with 
(anti)ecdysteroid activity also will affect other hormonally regulated processes in 
crustaceans [94]. Support for this hypothesis was recently provided by Mu and LeBlanc 
[109], who demonstrated that the fungicide fenarimol not only altered intermolt 
duration but also embryo development in daphnids by interfering with ecdysteroid 
metabolism. Developmental abnormalities were associated with suppressed ecdysone 
levels in the embryos and could be prevented by co-exposure to 20-HE. Anti-
ecdysteroid activity may provide a mean by which environmental chemicals impact 
crustacean species while not necessarily affecting vertebrates. However, in another 
study of Mu and LeBlanc [108], the vertebrate steroid hormone testosterone was shown 
to act as anti-ecdysteroid in vitro and in vivo giving rise to developmental toxicity 
similar to that observed for fenarimol. Interestingly, fenarimol is also known to act as 
androgen (via aromatase inhibition) as well as anti-androgen in vertebrate in vitro tests 
[110]. In a subsequent study, Mu and LeBlanc demonstrated synergistic effects of 
fenarimol on the embryotoxicity of testosterone [111]. Besides its embryotoxicity, 
testosterone delayed molting of daphnids indicated by a prolonged first intermolt period 
at 72 µg/l. This effect was mitigated by co-exposure to 20-HE. In A. tonsa, however, 
inhibition of larval development by testosterone occurred only at concentrations of 
0.74 mg/l (EC10) and 1.5 mg/l (EC50), which were close to acute toxic levels for adults. 
Thus, there is no indication of any specific toxic effect of testosterone in A. tonsa [3]. 
4.2.2 Ecdysteroid-Mimics 
The ecdysone-mimic RH 5849 (a bisacylhydrazine) is an insect growth regulator and 
acts as an ecdysteroid despite its nonsteroidal structure both in vitro [86;112] and in 
vivo [113] in insects. Evidence for a similar action in crustacean was provided by Clare 
et al. [90], who exposed larvae of the mud crab, Rhithropanopeus harrisii, and cypris 
larvae of the barnacle, B. amphitrite, to RH 5849 at concentrations ranging from 
0.1-10 mg/l. RH 5849 accelerated molting in the crab larvae (0.1 and 1.0 mg/l) and 
 32
caused death due to incomplete ecdysis (10 mg/l). Attachment and metamorphosis of 
barnacle cyprids were enhanced at 10 mg/l of RH 5849. Physiological ageing of larvae 
induced by RH 5849 was supposed to be the reason for increased attachment. The 
observed effect on metamorphosis was consistent with the known stimulatory effect of 
20-HE on this process in barnacles [114]. Tebufenozide is another bisacylhydrazine 
acting as an ecdysteroid receptor agonist, which is selectively toxic to lepidopteran 
(butterfly) species [115]. A few reports on the effects of this compound in crustaceans 
have been published. Song et al. [116] observed molt related acute toxicity at 
concentrations of 0.83 mg/l both in D. magna and Artemia spp., whereas Hirano et al. 
[117] found a NOEC of 10 mg/l in D. magna and Americamysis bahia. It would be 
interesting to test the effect of tebufenozide on larval development of A. tonsa.  
4.2.3 Juvenile Hormone-Analogues 
Another class of insect growth regulators are the juvenile hormone-analogues, which act 
as endogenous juvenile hormone and disrupt insect larval development and 
metamorphosis. Some of the JH-analogues, e.g. methoprene, have a structure similar to 
that of naturally occurring juvenile hormones from insects and to the crustacean 
hormone methylfarnesoate (MF). The insect hormone JH-III was a strong inhibitor of 
LDR in A. tonsa (EC50 = 100 µg/l, ACR>10) [3]. This observation is consistent with 
reports on the effect of JH-III on lobster larvae, in which a delay of metamorphosis 
occurred between 30 and 300 µg/l [118]. Two JH-analogues, fenoxycarb and 
methoprene, were tested in the present study. Fenoxycarb was even more potent in 
inhibiting larval development of A. tonsa than JH-III (EC10 =3 µg/l; EC50 = 27 µg/l) 
with a high ACR of about 30 (this study, unpublished data). In juvenile R. harrisii, 
fenoxycarb inhibited larval development (LOEC=48 µg/l) [119] and growth (100 µg/l) 
and reduced the total lipid content of the animals (50 µg/l) [120]. Thus, A. tonsa is more 
sensitive to fenoxycarb than R. harrisii. Neither fenoxycarb (this study, unpublished 
data) nor methoprene [86] showed in vitro ecdysteroid (anta)gonistic activity in the BII 
test. Methoprene altered LDR in A. tonsa with an EC50 of 230 µg/l (ACR=6) (this 
study, unpublished data). These findings are in-line with reported results on the effect 
of methoprene on various other species, which revealed delayed larval development. 
For instance, development of R. harrisii [121] and the grass shrimp, Palaemonetes 
pugio [122] was affected at a concentration of 100 mg/l. A study with blue crabs, 
Callinectes sapidus, revealed that methoprene alters exocytosis and deposition of 
cuticular components in connection with delayed molt to the first crab [123]. Moreover, 
mysid shrimps, Mysidopsis bahia, exposed to methoprene had a reduced weight (62 
µg/l), the release of the first brood was delayed and reproductive endpoints like number 
of offspring per brood were decreased [124]. In a study by Verslycke et al. [125], N. 
integer responded very sensitive to fenoxycarb (96-h LC50 = 0.53 mg/l) and methoprene 
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(96-h LC50 = 0.32 mg/l) exposure. These values are slightly below the 48-h LC50 found 
for A. tonsa (0.73 mg/l for fenoxycarb and 1.4 mg/l for methoprene) in this study. In 
addition, the short-term sublethal effect of methoprene on the energy and steroid 
metabolism of N. integer was evaluated [125]. Energy consumption was significantly 
induced at 100 µg/l, resulting in a lower cellular energy allocation in these animals. 
Methoprene exposure resulted in a concentration-dependent metabolic androgenisation. 
Verslycke et al. concluded that energy and testosterone metabolism of mysids are 
endpoints allowing to detect endocrine disrupting activity of chemicals after short-term 
exposure at environmentally relevant concentrations. Olmstead and LeBlanc [74] 
suggested that methoprene interferes with endocrine regulated processes in crustaceans 
by different mechanisms involving agonism and antagonism of various juvenoid 
receptor configurations. They demonstrated in this study with D. magna that 
methoprene has multiple mechanisms of toxicity leading to reduction in molt frequency, 
delayed first brood and reduced fecundity at concentrations in the low ng/l range.  
In another study, Olmsteadt and LeBlanc [126] found that the crustacean hormone MF 
is a male sex determinant in D. magna, since continuous exposure to MF stimulated a 
concentration dependent production of male-broods. After having demonstrated that, 
they showed that JH-analogues, e.g. pyriproxyfen, mimic the action of MF resulting in 
production of male offspring [127]. 
4.2.4 Chitin Synthesis Inhibitors 
A third group of insect growth regulators interfering with the molt process are the chitin 
synthesis inhibitors, which hamper normal development of the exoskeleton. These 
compounds do not act via the hormone system of the target organism indeed, but 
nevertheless they are interesting substances for comparison purposes because they often 
induce identical effects as substances affecting the ecdysteroid system. Diflubenzuron 
(Dimilin®) significantly inhibited molting in juvenile U. pugilator, at 20 and 200 µg/l 
[128]. A very interesting observation was made by Tester et al. [129], who exposed 
A. tonsa to Diflubenzuron. Females exposed to 1 and 10 µg/l produced fully developed 
eggs with moving nauplii visible inside the egg membrane. However, hatching of viable 
nauplii was significantly inhibited. Nauplii, which did hatch were abnormally shaped 
and failed to molt to the second naupliar stage. The nauplii were balloon-shaped with 
swollen appendages. Such balloon-shaped nauplii were never observed in A. tonsa at 
our laboratory, but were seen in N. spinipes exposed to 20-HE (Magnus Breitholtz, 
personal communication). 
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4.3 Vertebrate Steroid Hormones and Xeno-Hormones 
It was already known from work published in the seventies and eighties that for 
example cadmium and various organochlorines such as lindane, DDT, PCBs, and 
PCDFs may interfere with molting in higher crustaceans, e.g. decapods [130-133]. But 
starting point for the present study were the fundamental publications of Baldwin and 
LeBlanc [134] as well as Zou und Fingerman [73;135], from which it was obvious that 
estrogens affect the molting process in D. magna, possibly by interacting with the 
ecdysteroid receptor. Results of the present thesis work confirmed these findings in 
principle, but clearly demonstrated, that larval development in A. tonsa is more sensitive 
than molting in D. magna.  
LeBlanc and McLachlan [136] hypothesized that chemicals capable of binding to the 
vertebrate androgen receptor would also elicit toxicity to crustaceans by binding to 
specific steroid hormone receptors in an antagonistic manner. This hypothesis was 
tested by evaluating the effects of the antiandrogen cyproterone acetate on growth, 
molting, sexual differentiation, and reproduction of D. magna. Exposure of daphnids to 
concentrations of cyproterone acetate (130-2,100 µg/l) appreciably below those that 
elicited mortality reduced growth but had no effect on adult molting. Only at the highest 
concentration of 2,100 µg/l, molt frequency of juveniles was significantly reduced. 
These concentrations of cyproterone acetate had no effect on various developmental and 
maturation parameters. Cyproterone acetate also reduced the number of offspring 
produced by parthenogenetically reproducing daphnids, but this effect appeared to be a 
consequence of the reduced size of the daphnids and their inability to accommodate a 
brood of more than approximately 10 eggs. These results indicate that the antiandrogen 
cyproterone acetate specifically targets a process critical to growth of daphnids that is 
independent of molting. LeBlanc and McLachlan concluded that additional studies are 
needed to provide further evidence whether this molt independent growth reduction is 
an endocrine related toxicity to crustaceans that is associated with environmental 
antiandrogens. In A. tonsa, cyproterone acetate caused an inhibition of larval 
development with an EC10 of 81 µg/l and an EC50 of 156 µg/l (ACR=10) (this study, 
unpublished data), which are much lower than the LOEC of 2,100 µg/l reported for 
D. magna [136].  
In 1995, Baldwin and LeBlanc [134] published a study on the effect of the xeno-
estrogen diethylstilbestrol (DES) on D. magna. Chronic exposure of daphnids to 
500 µg/l of DES reduced molting frequency among first-generation juveniles and 
decreased fecundity of second-generation daphnids. Interestingly, molting frequency 
was not affected in juvenile second-generation daphnids. Increased DES 
 35
metabolism/elimination capabilities of prenatally exposed organisms were suggested as 
explanation. Additionally, steroid hormone metabolic capabilities of D. magna were 
investigated using testosterone as model steroid [134]. The rate of elimination of two 
major hydroxylated metabolites of testosterone was significantly reduced, and 
elimination of glucose conjugates of testosterone was significantly elevated when 
D. magna was exposed to 500 µg/l of DES. Competitive binding of DES to the 
ecdysteroid receptor was hypothesised as a possible explanation for the reduction in 
molting frequency. The LOEC of 500 µg/l of DES for reduced molting frequency in 
juvenile daphnids [134] was high compared to the corresponding EC10 of 12 µg/l 
(EC50=30 µg/l) found in A. tonsa (this study, unpublished data).  
Like Baldwin and LeBlanc, Zou and Fingerman [73] also studied the effect of DES on 
molting of D. magna. Neonates were exposed to DES (0.05, 0.10 and 0.20 mg/l) and to 
the estrogenic pesticide endosulfan (0.05, 0.10 and 0.15 mg/l). Molting frequency was 
measured by visually inspecting each animal every 12 h and record if molting had 
occurred. The completion of four molts took significantly longer in daphnids exposed to 
the two highest concentrations of both compounds. It should be noted that a high 
mortality of 20 to 50% occurred in the exposed groups compared to 20 % in the control. 
Next, Zou and Fingerman [135] investigated DEP, 4-OP, lindane, Aroclor 1242 and 
PCB29 at relatively high concentrations close to their acute toxic levels. DEP 
(LOEC=22.4 mg/l, ACR=3); Aroclor 1242 (LOEC=0.05 mg/l, ACR=5); and PCB29 
(LOEC=0.20 mg/l, ACR=6) significantly inhibited molting. Lindane (NOEC=0.20 
mg/l) and 4-OP (NOEC=0.04 mg/l) had no effect on molting. In another study with 
D. magna [137] following the method described by Zou and Fingerman [73] there was 
no effect of BPA on molting at concentrations up to 3.2 mg/l. In contrast, the EC50 
values for inhibition of A. tonsa larval development were 0.50 mg/l of BPA and 
0.013 mg/l of 4-OP [3]. DEP inhibited molting in D. magna with a LOEC of 22.4 mg/l 
[135], whereas 12 mg/l of DEP had no effect. Compared to these results, the EC50 for 
inhibition of A. tonsa larval development was just 10 mg/l [3]. Thus, the EC50 values for 
A. tonsa are lower than the reported NOECs found in D. magna for all three chemicals 
(BPA; 4-OP, and DEP). This demonstrates again that A. tonsa often responds much 
more sensitive to chemicals, which interfere with growth and molting processes than 
D. magna. The experiments with D. magna performed by Zou and Fingerman [73;135] 
and the larval development test with A. tonsa [3;4;6;8] have a lot in common. For 
instance, daphnids were exposed from neonates until the fourth instar (day 5-7 of the 
experiment). Thus, exposure was completed before reproduction started. Advantages of 
the A. tonsa test compared to the method applied by Zou and Fingerman are the low 
expenditure of human labour, its low cost and rapidness. Thus, high numbers of 
exposure concentrations and replicates are feasible, which allow the estimation of 
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concentration-response curves. From the D. magna experiments only NOECs and 
LOECs are obtained. Concentration-response relationships are beneficial because they 
strengthen the confidence with which the observed effects can be described.  
In-line with Baldwin and LeBlanc [134] Zou and Fingerman supported the hypothesis 
that some compounds capable of disrupting hormonal processes in vertebrates can also 
interfere with endocrine-mediated molting processes in arthropods, presumably by 
acting as antagonists of endogenous ecdysteroids [135]. For example, E2 and DES were 
recently shown to inhibit the binding of 3H-labelled PoA in an insect cell-line [138]. 
Alternative mechanisms of endocrine disruption such as the inhibition of 
ecdysteroidgenesis in the Y-organ were, however, not excluded by Zou and Fingerman 
[135].  
Five of the compounds tested for their ability to delay molting in D. magna (4-OP, 
DEP, DES, lindane and BPA) were later also investigated for their ecdysteroid 
(anta)gonistic activity in the BII cell assay [86]. Lindane and BPA acted as anti-
ecdysteroids in vitro. Just these two compounds did not affect molting in D. magna 
[135;137]. This indicates that other mechanisms than interaction with the ecdysteroid 
receptor were responsible for the delay in molting induced by DES and DEP in 
D. magna. However, BPA inhibited larval development in A. tonsa at concentrations 
much below the NOECs reported for D. magna [3], which in turn suggests different 
modes of action of BPA in D. magna and A. tonsa, respectively. 
In 1999, Zou and Fingerman published three studies [72;139;140], which finally 
provided a more specific explanation for the previously hypothesised ability of xeno-
estrogens to inhibit molting in D. magna. The subject of the first of these three papers 
[139] was the activity of a chitinolytic enzyme during the molting cycle in U. pugilator. 
Separation of the old exoskeleton, a process termed apolysis, occurs when the 
crustacean enters the proecdysis stage. Partial digestion of the old chitinous cuticle is 
brought about by the molting fluid in the apolytic space. This fluid is secreted by the 
epidermis and contains proteinases and two chitinolytic enzymes, chitinase and 
chitiobase. The authors investigated the activity of chitobiase in the epidermis and 
hepatopancreas during the molting cycle. The patterns of chitobiase activity correlated 
well with the hemolymph titer of ecdysteroids during the molting cycle suggesting that 
chitobiase activity in both tissues is regulated at least in part by the steroid molting 
hormones. Subsequently Zou and Fingerman studied the effects of exposure of 
U. pugilator to Aroclor 1242, DES, endosulfan, and 4-OP [140] as well as to 4-tert-OP, 
DEP, and PCB29 [72] on chitobiase activity. All these xeno-estrogens did inhibit 
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chitiobase activity in the epidermis and/or hepatopancreas significantly, but 4-OP only 
at high exposure levels. Because chitobiase is necessary for the partial digestion of the 
chitinous exoskeleton as part of the molting process, inhibition of this enzyme by 
estrogenic agents can account for at least some of the slowing down of molting that 
occurs when crustaceans are exposed to them. The authors concluded the following: 
Since chitinolytic enzymes are products of ecdysteroid regulated genes in arthropods, 
the decline in chitobiase along with the delayed molting strongly suggests that those 
xenobiotics disturb the Y-organ-ecdysteroid receptor axis. Such disturbance may be 
caused by an interaction between ecdysteroid receptors and steroid-mimics whereas the 
steroid-mimics act as antagonists of endogenous steroid molting hormones or arise from 
the interference of those compounds with the synthesis and excretion of ecdysteroids, or 
both. 
Whether such interactions described for a decapod can also take place in smaller 
crustaceans remains to be studied. There are various studies, primarily with copepods, 
in which no dose-related effects on development were reported in reference to 
interaction of estrogens with the molting process. For example, Bechmann [81] studied 
effects of nonylphenol (NP) in a life-cycle test with T. battagliai. The tested 
concentrations ranged from 31 to 500 µg/l. The highest concentrations (125 and 
500 µg/l) were lethal to nauplii, but no effects on development, sex ratio and fecundity 
were observed in this study. Moreover, Hutchinson et al. studied effects of DES [82] as 
well as E1, E2 and EE2 [105] on the life-cycle of T. battagliai. The turn from nauplii to 
copepodites was used to examine the effect of DES on development; a NOEC of 100 
µg/l of DES was determined. However, DES affected reproductive parameters and 
survival (21-d LOECs=100 µg/l). E1, E2, and EE2 were tested up to concentrations of 
100 µg/l, no effects on development, sex-ratio and fecundity of T. battagliai were 
observed. Breitholtz and Bengtsson [141] examined whether E2, EE2 and DES affect 
mortality, larval development rate, fecundity and sex ratio of N. spinipes in a life-cycle 
test similar to the method applied in the present study [5;7]. The only observed effect 
was a reduced percentage of gravid females at 30 µg/l of DES, which was the highest 
concentration tested. Neither E2 (NOEC=160 µg/l) nor EE2 (NOEC=50 µg/l) induced 
any measurable effects on larval development rate, fecundity and sex ratio. The same 
estrogens studied by Hutchinson et al. [82;105] as well as Breitholtz and Bengtsson 
[141] were investigated in the larval development test with A. tonsa, again demon-
strating that this copepod is more sensitive than other crustaceans [3]. Significant effects 
of estrogens on development of A. tonsa were seen at concentrations generally below or 
close to the NOECs obtained for inhibition of larval development of N. spinipes and 
development of T. battagliai. For example, LC10 values were 46 µg/l of EE2, 37 µg/l of 
E2 [3] and 12 µg/l of DES (this study, unpublished data). However, only for EE2 and 
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DES the calculated ACR (LC50/EC50) were above ten. Interestingly, EE2 has been 
shown to be a weak ecdysteroid antagonist in vitro [86]. 
The usefulness of small crustaceans like copepods for the evaluation of EDCs with 
regard to invertebrates has increasingly being recognised during the last years and has 
been reflected in recent publication on that issue, e.g. [5;7;78;81;82;95;105]). Partial 
and full life-cycle tests with copepods were established using e.g. the marine copepod 
A. tonsa [4;6], the intertidal copepod T. japonicus [106] the estuarine copepod 
Eurytemora affinis [142], the freshwater copepod Bryocamptus zschokkei [143] and the 
brackish copepod N. spinipes [5;7].  
For example, Marcial et al. [106] studied effects on development and reproduction in 
two successive generations of T. japonicus induced by continuous exposure to 
environmentally relevant concentrations of E2, BPA, 4-NP, 4-t-OP and 20-HE. Less 
than 24-h-old nauplii were exposed to four sublethal concentrations of those compounds 
for 21 d. Fecundity, sex ratio, and survival were not significantly affected; the NOEC of 
all tested compounds was 10 µg/l. However, all compounds affected development (time 
to reach copepodite stage and sexual maturity) in the first generation. The LOECs for 
effects on larval development were 1 µg/l of E2, 1 µg/l of 4-NP, 0.1 µg/l of BPA, 
0.1 µg/l of 4-t-OP, and 10 µg/L of 20-HE. Effects were apparent in the second 
generation, too. These values are low compared to other studies with copepods. For 
example, a LC10 of 5 µg/l of OP was obtained in the larval development test with 
A. tonsa [3]. It is, however, well known that branched alkylphenols have a higher in 
vitro estrogenic potency than the respective linear ones. NP affected timing of larval 
development of the barnacle Elminius modestus at very low NP concentrations ranging 
from 0.01-10 µg/l [144]. The LOECs for a delay of larval development obtained in the 
study with T. japonicus [106] seem extremely low compared to the acute toxic levels. 
ACRs calculated from 48-h LC50 and LOECs were as high as 500 (4-NP), 3,000 (E2), 
6,000 (4-t-OP) and 40,000 (BPA). Both, BPA and NP act as anti-ecdysteroid in vitro, 
whereby the activity of BPA is higher than that of NP [86]. This might partly explain 
why the ACR of BPA was much higher than those of the other estrogens. However, 
since the estrogens were investigated only at four different concentrations, no 
concentration response relationships were established.  
Five EDCs were investigated in a transgenerational life-cycle test with the estuarine 
copepod E. affinis [142] considering the endpoints survival, naupliar development, sex 
ratio, fecundity and number of broods. The most sensitive endpoint was larval 
development. Naupliar development was delayed (LOEC) at 109 µg/l of DEHP, 25 µg/l 
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of atrazine, 12 µg/l of benzo[a]pyrene, 7 µg/l of NP, and 6 µg/l of E2. Unfortunately, 
only a very few concentrations were tested so that no quantitative concentration 
response curves could be established allowing the calculation of ECX values.  
A full life-cycle test was performed to measure the effect of lindane (3.2-3,200 µg/l) on 
survival, development and reproduction of the freshwater copepod B. zschokkei [143]. 
Equi-proportional development, which assumes that each molt stage represents a certain 
proportion of the total development time and is not affected by processes that influence 
metabolism such as temperature and food quality, was used to determine the mode of 
action of lindane on developmental parameters. The time to reach the adult stage was 
significantly longer at 100 µg/l of lindane compared to the controls, but remained equi-
proportional regardless of lindane exposure. Prolonged development times, therefore, 
were not due to a direct effect of lindane on the molting process but were probably 
caused by reduced food intake or increased metabolism elicited by the stress imposed 
by toxicant exposure. Incorporating a copepod growth model (equiproportional 
development) into the life-cycle test design provided useful information on the 
dominant mode of action of lindane [143].  
4.4 Model Compounds 
After having demonstrated that larval development of A. tonsa was a very sensitive 
endpoint for evaluating effects of chemicals that might interfere with the endocrine 
system of crustaceans, the larval development test has been applied to two groups of 
emerging environmental contaminants, brominated flame retardants (BFRs) and 
synthetic musks, known or suspected to be potential endocrine disrupters. In addition, 
these substances were studied in the full life-cycle test with N. spinipes. To test for 
ecdysteroid agonistic/antagonistic activity the bioassay with the ecdysteroid-responsive 
D. melanogaster BII cell line was applied. The results of these investigations have been 
presented and discussed in detail in the papers [4-7]. Therefore, just a summary of the 
most important results will be given below  
Brominated Flame Retardants (BFRs) have entered the aquatic environment and have 
now been detected in freshwater and marine organisms as well as sediments from many 
locations around the world [24]. Toxicity studies with BFRs have mainly been 
performed on mammals as yet. Their acute toxicity seems to be low, but there is 
concern about various chronic effects. Some BFRs hav shown to act as reproductive, 
developmental, immuno- and neurotoxins. They induce certain liver enzymes and act as 
endocrine disrupters, especially on the thyroid system, but estrogen receptor binding has 
 40
also been reported [24;145-147]. For the time being, knowledge about the impact of 
BFRs on aquatic organisms is very limited. A primary contribution of the present work 
with BFRs was to establish data on their ecotoxicity.  
Subchronic effects of tetrabromobisphenol A (TBBPA), tribromophenol (TBP) and four 
polybrominated diphenyl ethers, PBDEs (BDE-28, BDE-47, BDE-99 and BDE-100) on 
larval development of A. tonsa were studied in paper [6]. For TBBPA and TBP 5d-EC50 
values for inhibition of the larval development rate were 125 and 810 µg/l, respectively, 
whereas the PBDEs were much more potent with 5d-EC50 in the low µg/l range 
(1.2 µg/l for BDE-100; 4.2 µg/l for BDE-99; 13 µg/l for BDE-28 and 13 µg/l for BDE-
47). These concentrations were up to two orders of magnitude below the 48h-LC50 for 
acute adult toxicity (108 µg/l for BDE-28; 400 µg/l for TBBPA; 520 µg/l for BDE-100; 
705 µg/l for BDE-99; 1,500 µg/l for TBP and 2,370 µg/l for BDE-47). To distinguish 
between general toxicological and endocrine-mediated toxic effects, the BFRs were 
assessed in vitro for ecdysteroid agonistic/antagonistic activity. The pentabrominated 
diphenyl ethers BDE-99 and BDE-100 showed weak ecdysteroid antagonistic activity. 
Thus, these PBDEs may be regarded as potential endocrine disrupters in invertebrates. 
The combination of in vitro assays and subchronic biotests with ecologically important 
crustacean species was shown to be a rapid and cost-effective tool when screening for 
sublethal effects of chemicals. 
The full life-cycle test with N. spinipes was used to study effects of BDE-47, -99 and 
-100 on LDR and population growth rate [7]. LDR significantly decreased in copepods 
exposed for 6 days to nominal concentrations ≥ 13 µg/l of BDE-47 and ≥ 30 µg/l of 
BDE-99. High ACRs (up to 340) between adult acute and juvenile subchronic toxicity 
were observed. Exposure over the full life cycle showed in general that population 
growth rate was a less sensitive endpoint than LDR. Still, the population growth rate in 
copepods exposed to 40 µg/l of BDE-47 was significantly reduced compared to the 
controls. Partitioning experiments with 14C-labelled BDE-47 and BDE-99 in the test 
system showed that the major fractions of both compounds (50-80%) were adsorbed to 
particulate material. These findings indicate that development and reproduction in 
N. spinipes are sensitive to the tested PBDEs and that ingestion of particle-adsorbed 
PBDEs most likely is the predominant route of exposure in this species.  
A nitro musk (musk ketone - MK) and three polycyclic musks (Tonalide - AHTN, 
Galaxolide - HHCB and Celestolide - ADBI) were tested for acute and subchronic 
effects on A. tonsa [4] using the methods described elsewhere [3;6]. The inhibition of 
LDR after 5 days exposure was demonstrated to be a very sensitive endpoint, with 
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5d-EC50 values as low as 26 µg/l (AHTN) 59 µg/l (HHCB), 66 µg/l (MK) and 160 µg/l 
(ADBI), respectively. These values were generally more than one order of magnitude 
below the 48-h LC50 values found for adults, which were 0.47 mg/l (HHCB), 0.71 mg/l 
(ADBI), 1.32 mg/l (MK) and 2.5 mg/l (AHTN). Since the synthetic musks strongly 
inhibited larval development in A. tonsa at low nominal concentrations, they should be 
considered as very toxic. The larval development test with A. tonsa was shown to be 
able to provide important aquatic toxicity data for the evaluation of the environmental 
risk of synthetic musks, for which there has been little ecotoxicological information 
available regarding crustaceans so far. It was suggested that subchronic and chronic 
copepod toxicity tests due to their high sensitivity to potential EDCs and other specific 
toxic compounds should be incorporated in the risk assessment of environmental 
pollutants routinely. 
The same four synthetic musks were investigated in the full life-cycle test with 
N. spinipes [5]. The LDR, was recorded after 7-8 days exposure of juveniles and was 
significantly decreased in copepods exposed to sublethal concentrations of MK, ADBI 
and HHCB. However, none of the AHTN concentrations had any effect on larval 
development. The lowest HHCB concentration (0.02 mg/l), which affected juvenile 
development, was about 100 times below the adult 96h-LC50 value of 1.9 mg/l. In the 
BII cell assay, none of the four musks showed any agonistic or antagonistic activity. 
This indicates that the decrease in larval development rate was due to general toxic 
effects rather than steroid receptor-mediated endocrine disruption. A modified Euler-
Lotka equation was used to calculate a population-level endpoint, the intrinsic rate of 
natural increase, from individual life-table endpoints, i.e. mortality rate, time of release 
of first brood, sex ratio, the fraction of ovigerous females among all females as well as 
the number of nauplii per ovigerous female. This population-level endpoint was affected 
significantly at the second highest MK concentration (0.1 mg/l) only. At the highest MK 
(0.3 mg/l) and ADBI (0.3 mg/l) concentrations, all copepods were dead at the end of the 
exposures. The results demonstrated that it is possible to obtain population-level data 
from the full life-cycle test with N. spinipes. 
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re
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 m
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at
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 p
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 p
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 p
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 p
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 m
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 m
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 p
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 p
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r C
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 p
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 m
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 p
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du
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 d
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ra
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 c
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at
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 p
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ra
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 p
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 p
ai
rs
 a
nd
 g
ra
vi
d 
fe
m
al
es
, 1
3.
5 
µg
/l 
[1
57
]
H
ya
le
lla
 a
zte
ca
 
(a
du
lt)
 
Li
nd
an
e 
D
ire
ct
 a
nd
 in
di
re
ct
 se
pa
ra
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 m
at
ur
at
io
n 
[1
60
] 
Fi
el
d 
sa
m
pl
es
 
C
la
do
ce
ra
ns
 
 
 
 
 
C
er
od
ap
hn
ia
 d
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 re
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 fe
cu
nd
ity
 (n
o 
ef
fe
ct
 o
n 
ju
ve
ni
le
 m
ol
tin
g 
fr
eq
ue
nc
y)
 1
2-
50
 µ
g/
l 
[7
1]
D
ap
hn
ia
 m
ag
na
 
(ju
ve
ni
le
) 
En
do
su
lfa
n,
 D
ES
 
M
ol
t i
ni
hi
bi
tio
n,
 1
 a
nd
 1
.5
 m
g/
l e
nd
os
ul
fa
n,
 0
.1
 a
nd
 0
.2
 m
g/
l D
ES
 
[7
3]
 
 
D
ap
hn
ia
 m
ag
na
 
PC
B
29
 (a
), 
A
ro
cl
or
 1
24
2 
(b
), 
D
EP
 (c
), 
4-
O
P 
(d
), 
lin
da
ne
(e
) 
Pr
ol
on
ge
d 
 ti
m
e 
pe
rio
d 
to
 c
om
pl
et
e 
fo
ur
 m
ol
ts
, 0
.2
 m
g/
l (
a)
, 0
.0
5 
an
d 
0.
10
 m
g/
l (
b)
, 2
2.
4 
m
g/
l (
c)
, N
O
EC
 =
 0
.0
4 
m
g/
l (
d)
, N
O
EC
 =
 0
.2
0 
m
g/
l (
e)
 
[1
35
]
D
ap
hn
ia
 sp
. 
La
ke
 M
en
do
ta
, W
is
co
ns
in
,
U
.S
. 
D
ec
lin
e 
in
 m
ax
im
um
 fr
eq
ue
nc
y 
of
 m
al
es
 si
nc
e 
19
40
 
[9
3]
 
Fi
el
d 
st
ud
y 
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T
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 c
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D
ap
hn
ia
 p
ul
ex
 
M
et
ho
pr
en
e 
(a
), 
20
-H
E 
(b
)
D
ec
re
as
e 
in
 a
ll-
m
al
e 
br
oo
ds
, i
nc
re
as
e 
in
 a
ll-
fe
m
al
e 
br
oo
ds
 1
0 
an
d 
10
0 
µg
/l 
(a
) a
nd
 1
00
 
µg
/l 
(b
); 
de
cr
ea
se
 in
 a
ll-
m
al
e 
br
oo
ds
, d
ec
re
as
e 
in
 a
ll-
fe
m
al
e 
br
oo
ds
, 1
 a
nd
 1
0 
µg
/l 
(b
) 
[1
78
]
D
ap
hn
ia
 p
ul
ex
, 
D
iu
ro
n 
D
ec
re
as
ed
 re
pr
od
uc
tio
n,
 L
O
EC
 =
 7
.7
 m
g/
l 
[1
79
] 
 
D
ap
hn
ia
 p
ul
ic
ar
ia
 
(a
du
lt)
 
A
tra
zi
ne
 
In
cr
ea
se
d 
m
al
e 
pr
od
uc
tio
n,
 0
.5
 a
nd
 1
0 
µg
/l 
[1
80
] 
 
M
oi
na
 m
ac
ro
co
pa
 
(n
eo
na
te
-a
du
lt)
 
(S
)-
m
et
ho
pr
en
e 
R
ed
uc
ed
 fe
cu
nd
ity
, 0
.0
5-
0.
5 
m
g/
l 
[1
81
] 
 
C
op
ep
od
s 
 
 
 
 
Ac
ar
tia
 to
ns
a 
(e
gg
-ju
ve
ni
le
) 
TB
T 
In
hi
bi
tio
n 
of
 la
rv
al
 d
ev
el
op
m
en
t, 
EC
10
 =
1 
ng
/l,
 E
C
50
=3
 n
g/
l 
[7
8]
 
 
Ac
ar
tia
 to
ns
a 
D
ifl
ub
en
zu
ro
n 
R
ed
uc
ed
 e
gg
 v
ia
bi
lit
y,
 m
or
ph
ol
og
ic
al
 a
bn
or
m
al
iti
es
, s
ta
ge
 I 
na
up
lii
 u
na
bl
e 
to
 m
ol
t, 
1-
10
 
µg
/l;
 re
du
ce
d 
fe
cu
nd
ity
,1
00
 µ
g/
l 
[1
29
] 
 
Ac
ar
tia
 to
ns
a 
(e
gg
-ju
ve
ni
le
) 
E2
 (a
), 
E1
 (b
), 
te
st
os
te
ro
ne
 
(c
), 
pr
og
es
te
ro
ne
 (d
), 
20
-
H
E 
(e
), 
JH
-I
II
 (f
), 
flu
ta
m
id
e 
(g
), 
ta
m
ox
ife
n 
(h
), 
hy
dr
ox
yf
lu
ta
m
id
e 
(i)
, 
EE
2 
(j)
, 4
-O
P 
(k
), 
B
PA
 (l
), 
N
PE
O
 (m
), 
D
EH
P 
(n
) 3
,4
-
D
C
A
 (o
) 
In
hi
bi
tio
n 
of
 la
rv
al
 d
ev
el
op
m
en
t, 
EC
10
 (m
g/
l):
 0
.3
7 
(a
), 
0.
25
 (b
), 
0.
74
 (c
), 
0.
01
7 
(f
), 
0.
13
5 
(g
), 
0.
00
87
 (h
), 
0.
00
53
 (i
), 
0.
04
6 
(j)
, 0
.0
05
2 
(k
), 
0.
10
 (l
), 
0.
02
2 
(m
), 
5.
0 
(n
), 
0.
38
 
(o
); 
EC
50
 (m
g/
l):
 0
.7
2 
(a
), 
0.
41
 (b
), 
1.
5 
(c
), 
0.
10
2 
(f
), 
0.
48
 (g
), 
0.
04
9 
(h
), 
1.
4 
(i)
, 0
.0
88
 (j
), 
0.
01
3 
(k
), 
0.
55
 (l
), 
0.
15
 (m
), 
10
 (n
), 
0.
54
 (o
); 
N
O
EC
 (m
g/
l):
 1
.0
 (d
), 
1.
5 
(e
); 
ac
ut
e-
to
-c
hr
on
ic
 ra
tio
 >
10
 (f
, g
, j
, k
, m
, o
) 
[3
]   
 
Ac
ar
tia
 to
ns
a 
(e
gg
-ju
ve
ni
le
) 
Po
A
 (a
), 
m
et
ho
pr
en
e 
(b
), 
fe
no
xy
ca
rb
 (c
), 
p,
p’
-D
D
E 
(d
), 
C
PA
 (e
), 
vi
nc
lo
zo
lin
 
(f
) D
ES
 (g
), 
IC
I 1
82
 (h
), 
N
P 
ac
et
at
e 
(i)
 
St
im
ul
at
io
n 
of
 la
rv
al
 d
ev
el
op
m
en
t a
t 0
.0
00
6-
0.
00
16
 m
g/
l (
a)
; i
nh
ib
iti
on
 o
f l
ar
va
l 
de
ve
lo
pm
en
t r
at
e 
EC
10
 (m
g/
l):
 0
.1
66
 (b
), 
0.
00
3(
c)
, 0
.0
00
1 
(d
), 
0.
08
 (e
), 
0.
63
 (f
), 
0.
02
 (g
), 
1.
65
 (h
), 
0.
7 
(i)
; i
nh
ib
iti
on
 o
f l
ar
va
l d
ev
el
op
m
en
t E
C
50
 (m
g/
l):
 0
.2
26
 (b
), 
0.
02
7 
(c
), 
0.
00
2 
(d
), 
0.
15
6 
(e
), 
3.
53
 (f
), 
0.
03
0 
(g
), 
1.
98
 (h
), 
3.
60
 (i
) 
[t
hi
s s
tu
dy
, 
un
pu
bl
is
he
d 
da
ta
] 
 
 
Ac
ar
tia
 to
ns
a 
(e
gg
-ju
ve
ni
le
) 
Sy
nt
he
tic
 m
us
ks
: M
K
 (a
), 
H
H
C
B
 (b
), 
A
H
TN
 (c
), 
A
D
B
I (
d)
 
In
hi
bi
tio
n 
of
 la
rv
al
 d
ev
el
op
m
en
t, 
EC
10
 (µ
g/
l):
 1
0 
(a
), 
37
 (b
), 
7 
(c
), 
36
 (d
); 
EC
50
 (µ
g/
l):
 
66
 (a
), 
59
 (b
), 
26
 (c
), 
16
0 
(d
); 
ac
ut
e-
to
-c
hr
on
ic
 ra
tio
: 2
0 
(a
), 
8 
(b
), 
27
 (c
), 
16
 (d
); 
[4
]  
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Ac
ar
tia
 to
ns
a 
(a
du
lt)
 
20
-H
E 
(a
), 
JH
-I
II
 (b
), 
E1
 
(c
), 
E2
 (d
), 
EE
2 
(e
), 
pr
og
es
te
ro
ne
 (f
), 
D
ES
 (g
), 
te
st
os
te
ro
ne
 (h
), 
m
et
hy
l-
te
st
os
te
ro
ne
 (i
), 
flu
ta
m
id
e 
(j)
, N
PE
O
10
 (k
), 
D
C
A
 (l
), 
B
PA
 (m
), 
TB
B
PA
 (n
)  
R
ed
uc
ed
 fe
m
al
e 
fe
cu
nd
ity
 (m
ea
su
re
d 
as
 e
gg
 p
ro
du
ct
io
n)
 
EC
10
 (m
g/
l):
 0
.1
 (a
), 
0.
00
3 
(b
), 
0.
27
 (d
), 
0.
04
2 
(f
), 
0.
03
 (h
), 
0.
46
 (i
), 
0.
26
5 
(k
), 
0.
73
4 
(l)
, 
0.
02
1 
(m
), 
0.
11
2 
(n
)  
N
O
EC
 (m
g/
l):
 0
.1
 (c
), 
0.
1 
(e
), 
0.
1 
(g
), 
1.
0 
(j)
 
EC
50
 (m
g/
l):
 0
.6
5 
(b
), 
0.
98
 (d
) 
 
[t
hi
s s
tu
dy
, 
un
pu
bl
is
he
d 
da
ta
] 
 
Ac
ar
tia
 to
ns
a 
(e
gg
-a
du
lt)
 
E2
, B
PA
 
A
cc
el
er
at
ed
 se
xu
al
 m
at
ur
at
io
n 
of
 fe
m
al
es
, 2
3 
µg
/l 
E2
; 2
0 
m
g/
l B
PA
 
[1
82
] 
 
Ac
ar
tia
 to
ns
a 
(e
gg
-ju
ve
ni
le
) 
PB
D
Es
: B
D
E-
28
 (a
), 
B
D
E 
47
 (b
), 
B
D
E-
99
 (c
); 
B
D
E-
10
0 
(d
); 
TB
P 
(e
) 
TB
B
PA
 (f
) 
In
hi
bi
tio
n 
of
 la
rv
al
 d
ev
el
op
m
en
t, 
EC
10
 (µ
g/
l):
 4
.6
 (a
), 
2.
4 
(b
), 
0.
39
 (c
), 
0.
02
 (d
), 
27
0 
(e
), 
13
 (f
); 
EC
50
 (µ
g/
l):
 1
2.
8 
(a
), 
12
.5
 (b
), 
4.
2 
(c
), 
1.
2 
(d
), 
81
1 
(e
), 
12
5 
(f
); 
ac
ut
e-
to
-c
hr
on
ic
 
ra
tio
: 1
90
 (b
), 
45
0 
(d
), 
17
0 
(c
); 
w
ea
k 
ec
dy
st
er
oi
d 
ac
tiv
ity
 o
f (
c)
 a
nd
 (d
) i
n 
vi
tro
 (B
II
 te
st
) 
[6
]  
 
Am
ph
ia
sc
us
 te
nu
ir
em
is
 
(tr
an
s-
ge
ne
ra
tio
na
l) 
Fi
pr
on
il 
R
ed
uc
ed
 re
pr
od
uc
tio
n 
du
e 
to
 m
al
e 
in
fe
rti
lit
y,
 0
.6
3 
µg
/l 
[1
83
] 
 
Am
ph
ia
sc
us
 te
nu
ir
em
is
 
(ju
ve
ni
le
) 
Fi
pr
on
il 
In
du
ct
io
n 
of
 li
po
vi
te
lli
n 
in
 fe
m
al
es
 (n
ot
 in
 m
al
es
), 
0.
6 
µg
/l 
[5
7]
 
 
Am
ph
ia
sc
us
 te
nu
ir
em
is
 
(li
fe
-c
yc
le
) 
Fi
pr
on
il 
St
ro
ng
 in
hi
bi
tio
n 
of
 re
pr
od
uc
tio
n,
 d
el
ay
ed
 d
ev
el
op
m
en
t, 
≥0
.2
2 
µg
/l;
 d
ec
lin
e 
in
 m
od
el
le
d 
po
pu
la
tio
n 
si
ze
, 0
.1
6 
m
g/
l 
[1
84
] 
 
 
 
 
 
 
 
 
 
Am
ph
ia
sc
us
 te
nu
ir
em
is
 
A
tra
zi
ne
 
R
ep
ro
du
ct
iv
e 
fa
ilu
re
 in
 F
1 
ge
ne
ra
tio
n,
 2
5 
an
d 
25
0 
µg
/l;
 c
op
ep
od
 m
al
fo
rm
at
io
n 
(F
1 
ge
ne
ra
tio
n)
 a
nd
 d
ec
lin
e 
in
 m
od
el
le
d 
po
pu
la
tio
n 
si
ze
 (2
.5
, 2
5 
an
d 
25
0 
µg
/l)
 
[1
85
]
Br
yo
ca
m
pt
us
 zs
ch
ok
ke
i 
(li
fe
-c
yc
le
) 
Li
nd
an
e 
D
el
ay
ed
 d
ev
el
op
m
en
t (
bu
t s
til
l e
qu
ip
ro
po
rti
on
al
), 
10
0 
µg
/l;
 re
du
ce
d 
eg
g 
pr
od
uc
tio
n 
an
d 
of
fs
pr
in
g 
vi
ab
ili
ty
, 3
2 
µg
/l 
[1
43
]
H
ar
pa
ct
ic
oi
d 
co
pe
po
ds
, 
fo
ur
 sp
ec
ie
s 
Fi
rth
 o
f F
ou
rth
, S
co
tla
nd
 
In
te
rs
ex
 
[9
2;
18
6]
Fi
el
d 
st
ud
y
Ni
to
cr
a 
sp
in
ip
es
 
(n
eo
na
te
-a
du
lt)
 
E2
 (a
), 
EE
2 
(b
), 
D
ES
 (c
) 
N
o 
ef
fe
ct
 o
n 
la
rv
al
 d
ev
el
op
m
en
t, 
se
x 
ra
tio
 a
nd
 fe
cu
nd
ity
, 0
.5
-5
0 
µg
/l 
(a
 a
nd
 b
); 
re
du
ce
d 
pe
rc
en
ta
ge
 o
f g
ra
vi
d 
fe
m
al
es
, 3
0 
µg
/l 
(c
)  
[1
41
]
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Ni
to
cr
a 
sp
in
ip
es
 
(li
fe
-c
yc
le
) 
PB
D
Es
: B
D
E-
47
 (a
), 
 
B
D
E-
99
 (b
), 
B
D
E-
10
0 
(c
) 
In
hi
bi
tio
n 
of
 la
rv
al
 d
ev
el
op
m
en
t, 
≥1
3 
µg
/l 
(a
), 
≥ 
30
 µ
g/
l (
b)
, a
cu
te
-to
-c
hr
on
ic
 ra
tio
s a
bo
ve
 
30
0;
 p
op
ul
at
io
n 
gr
ow
th
 ra
te
 re
du
ce
d,
 4
0 
µg
/l 
(a
) 
[7
]   
 
Ni
to
cr
a 
sp
in
ip
es
 
(li
fe
-c
yc
le
) 
Sy
nt
he
tic
 m
us
ks
: M
K
 (a
), 
H
H
C
B
 (b
), 
A
H
TN
 (c
), 
A
D
B
I (
d)
 
In
hi
bi
tio
n 
of
 la
rv
al
 d
ev
el
op
m
en
t, 
, ≥
30
 µ
g/
l (
a)
, ≥
 2
0 
µg
/l 
(b
), 
10
0 
µg
/l 
(c
), 
ac
ut
e-
to
-
ch
ro
ni
c 
ra
tio
 1
00
 (b
); 
po
pu
la
tio
n 
gr
ow
th
 ra
te
 re
du
ce
d,
 1
00
 µ
g/
l (
a)
; n
o 
ec
dy
st
er
oi
d 
ac
tiv
ity
 
in
 v
itr
o 
(a
, b
, c
, d
) 
[5
]  
 
Ti
sb
e 
ba
tta
gl
ia
i 
(li
fe
-c
yc
le
) 
20
-H
E,
 D
ES
 
R
ed
uc
ed
 re
pr
od
uc
tio
n 
(2
7 
µg
/l 
20
 H
E)
; n
o 
br
ee
di
ng
 fe
m
al
es
 ≥
86
.5
 µ
g/
l 2
0-
H
E,
 1
00
 µ
g/
l 
D
ES
, (
no
 e
ff
ec
t o
n 
na
up
lia
r d
ev
el
op
m
en
t a
nd
 se
x 
ra
tio
)  
[8
2]
 
 
 
 
 
 
 
 
 
Ti
sb
e 
ba
tta
gl
ia
i 
(li
fe
-c
yc
le
) 
E2
, E
1,
 E
E2
 
 
N
o 
ef
fe
ct
 o
n 
de
ve
lo
pm
en
t, 
se
x 
ra
tio
 a
nd
 re
pr
od
uc
tio
n,
 0
.1
-1
00
 µ
g/
l f
or
 a
ll 
co
m
po
un
ds
 
[1
05
] 
 
Ti
sb
e 
ba
tta
gl
ia
i 
(m
ul
ti-
ge
ne
ra
tio
na
l) 
N
P 
N
o 
ef
fe
ct
 o
n 
de
m
og
ra
ph
ic
 p
ar
am
et
er
s, 
31
µg
/l;
 p
op
ul
at
io
n 
is
 c
ol
la
ps
in
g,
 6
2 
µg
/l 
[8
1]
 
 
Ti
gr
io
pu
s j
ap
on
ic
us
 
(m
ul
ti-
ge
ne
ra
tio
na
l) 
E2
 (a
); 
B
PA
 (b
), 
4-
N
P 
(c
), 
p-
t-O
P 
(d
), 
20
-H
E 
(e
) 
D
el
ay
 in
 c
om
pl
et
io
n 
of
 n
au
pl
ia
r s
ta
ge
s (
F1
 g
en
er
at
io
n 
m
or
e 
se
ns
iti
ve
), 
1 
µg
/l 
(a
), 
1 
an
d 
10
 
µg
/l 
(c
), 
0.
1-
10
 m
g/
l (
b)
, 0
.1
 a
nd
 1
 µ
g/
l (
d)
; n
o 
de
ve
lo
pm
en
ta
l e
ff
ec
ts
 o
f (
e)
; n
o 
ef
fe
ct
s o
n 
fe
cu
nd
ity
 a
nd
 se
x 
ra
tio
, e
xc
ep
t 0
.0
1 
µg
/l 
(a
) (
m
or
e 
fe
m
al
es
); 
te
st
ed
 ra
ng
e 
fo
r a
ll 
co
m
po
un
ds
 0
.0
1 
– 
10
 µ
g/
l 
[1
06
]
D
ec
ap
od
s
Ba
la
nu
s a
m
ph
itr
ite
 
(c
yp
rid
 la
rv
a)
 
E2
, 4
-N
P 
In
hi
bi
tio
n 
of
 b
ar
na
cl
e 
se
ttl
em
en
t, 
0.
01
-1
0 
µg
/l,
 b
ot
h 
co
m
po
un
ds
  
[1
87
] 
 
Ba
la
nu
s a
m
ph
itr
ite
 
(c
yp
ris
 la
rv
a)
 
R
H
 5
84
9 
 
En
ha
nc
ed
 a
tta
ch
m
en
t a
nd
 m
et
am
or
ph
os
is
, 1
0 
m
g/
l 
[9
0]
 
 
Ba
la
nu
s a
m
ph
itr
ite
 
(c
yp
ris
 la
rv
a)
 
E2
; 4
-n
-N
P 
In
du
ct
io
n 
of
 c
yp
ris
 m
aj
or
 p
ro
te
in
 (v
ite
lli
n-
lik
e 
pr
ot
ei
n)
, 1
 µ
g/
l, 
bo
th
 c
om
po
un
ds
 
[5
5]
 
 
C
al
lin
ec
te
s s
ap
id
us
 
(la
rv
a-
ad
ul
t) 
M
et
ho
pr
en
e 
R
ed
uc
ed
 h
at
ch
in
g 
su
cc
es
s, 
le
th
ar
gi
c 
be
ha
vi
ou
r, 
in
hi
bi
tio
n 
of
 m
et
am
or
ph
os
is
, 0
.6
-3
 m
g/
l  
[1
23
] 
 
Ca
rd
in
a 
ra
ja
dh
ar
i 
(a
du
lt)
 
TB
T 
ox
id
e 
D
ec
re
as
ed
 c
al
ci
um
 re
so
rp
tio
n 
fr
om
 th
e 
ex
os
ke
le
to
n,
 1
5 
– 
40
 n
g/
l 
[1
88
] 
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Ch
as
m
ag
na
th
us
 g
ra
nu
la
ta
 
(a
du
lt)
 
C
ad
m
iu
m
, c
op
pe
r 
H
yp
og
ly
ce
m
ia
 (i
nh
ib
iti
on
 o
f C
H
H
 se
cr
et
io
n)
, 0
.5
 m
g/
l C
d,
 1
 m
g/
l C
u 
[1
89
] 
 
Ch
as
m
ag
na
th
us
 g
ra
nu
la
ta
 
(ju
ve
ni
le
) 
C
ad
m
iu
m
 
R
ed
uc
ed
 m
ol
tin
g 
fr
eq
ue
nc
y,
 1
0 
an
d 
50
 µ
g/
l 
[1
90
] 
 
El
im
in
us
 m
od
es
tu
s 
(la
rv
a)
 
Fa
rn
es
ol
  
D
is
tu
rb
ed
 a
tta
ch
m
en
t a
nd
 m
et
am
or
ph
os
is
, 5
 x
 1
0 
–7
 –
 1
0 
–6
 (v
/v
) 
[1
91
] 
 
El
m
in
iu
s m
od
es
tu
s 
(n
eo
na
te
-c
yp
ris
 la
rv
a)
 
E2
; 4
-n
-N
P 
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Table 5 Unpublished results of 48 h acute toxicity tests, larval development tests with A. tonsa 
expressed in mg/l (µg/l in case of DDE) and calculated acute-to-chronic toxicity 
ratios (ACR). 95% confidence intervals were given if possible 
Test compound 48 h acute test 
 with A. tonsa 
Larval development test  
with A. tonsa 
 
ACR  
 LC10 LC50 EC10 EC50. LC50/EC50a) 
Ponasterone A NOEC = 1.25 LOEC = 0.00064b) 780a) 
     
Diethylstilbestrol 0.17 0.34 0.012 0.030 11 
 (0.10-0.26) (0.25-0.39) (0.005-0.03) (0.02-0.046)  
ICI 182, 780 NOEC = 2.0 1.65 1.98 ≥1 
  (0.34-79) (1.68-234)  
Cyproterone acetate 0.008 1.5 0.08 0.16 10 
  (0.94-3.93) (0.005-1.23) (0.04-0.61)  
Vinclozolin 2.5 5.3 0.64 3.53 1.5 
 (1.5-3.3) (4.6-6.5) (0.17-2.33) 1.27-9.84  
p,p’-DDEc) 35 c) 83 c)  0.083 c)  1.77 c) 47 
   (0.008-0.84) c) (0.4-8.0) c)  
Methoprene 0.39 1.4 0.165 0.226 6 
 (0.09-0.62) (1.12-1.98) (0.008-0.36) (0.014-0.35)  
Fenoxycarb 0.09 0.73 0.003 0.027 27 
 (0.03-0.17) (0.48-1.27) (0.0006-0.016) (0.014-0.052)  
Nonylphenol acetated) 2.7 3.6 0.70 1.01 4 
 (2.1-3.2) (3.1-4.2) (0.32-1.53) (0.72-1.53)  
a) In case of Ponasterone A NOEC/LOEC=ACR 
b) Stimulation (30%) of larval development compared to control 
c) Concentrations are given in µg/l 
d) Metabolite of nonylphenol ethoxylates 
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5 Conclusion and Perspective 
The results of the experimental work as well as the literature survey demonstrated 
clearly that marine copepods such as Acartia tonsa and Nitocra spinipes are suitable and 
very sensitive test organisms to study sublethal effects of specific toxic chemicals 
including compounds suspected to be potential EDCs. Their short generation times of 
two to three weeks allow performing partial as well as full life-cycle tests. 
In preliminary studies with A. tonsa various parameters related to processes regulated 
by hormones such as growth, molting, sexual maturation, and offspring production were 
investigated. Endpoints were for example larval development ratio, egg production and 
sex ratio. Exposure experiments were conducted with naturally occurring and synthetic 
vertebrate and invertebrate hormones as well as compounds known to act as endocrine 
disrupters in vertebrates in vitro or in vivo. Larval development ratio was identified to 
be a remarkably sensitive endpoint. The larval development test with A. tonsa is rapid, 
cost-effective, easily to perform and responds very sensitive to low concentration 
exposure with a number of chemicals with the results that full concentration-response 
relationships are obtained allowing the determination of effective concentrations (ECx). 
These altogether are big advantages compared to other frequently used (sub)chronic 
toxicity tests with crustaceans. 
After having demonstrated that larval development ratio in A. tonsa was a very sensitive 
endpoint for evaluating effects of chemicals that might interfere with the endocrine 
system of crustaceans, the test has been applied to two groups of emerging 
environmental contaminants, brominated flame retardants and synthetic musks, known 
or suspected to be potential endocrine disrupters. 
In doing so, important information on the chronic toxicity of these sparsely investigated 
groups of substances were attained, which might be of great importance for environ-
mental risk assessment of those compounds, since the measured ECx values were at 
least partly lower than any previously reported effective concentrations determined in 
crustaceans. For example, for the polycyclic musks HHCB and AHTN EC50 values of 
60 and 26 µg/l, respectively, were obtained in the larval development test, which were 
obviously one order of magnitude lower than the corresponding 21 d EC50 for 
D. magna. Even the reported 21-d NOECs for HHCB and AHTN of 110 and 200 µg/l, 
respectively, were much higher than the EC50 values seen in the A. tonsa test. 
In parallel, synthetic musks as well as brominated flame retardants were investigated in 
a full life-cycle test with N. spinipes. This test allows studying larval development ratio 
 55
as well as other individual life-table endpoints, which enable the calculation of 
population-level endpoints, e.g. the intrinsic rate of natural increase. In N. spinipes, 
larval development ratio has been proven to be the most sensitive endpoint too. 
Though the majority of crustacean species rely entirely on sexual reproduction for their 
recruitment, the most often applied international guideline to test for effects on 
crustacean reproduction to date is based on parthonogenesis in Daphnia magna. 
Standardised methods for testing chronic toxicity with sexually reproducing species are 
urgently needed, particularly for the evaluation of chemicals suspected to disrupt the 
endocrine system. Thus, the OECD Draft Guidelines for Testing of Chemicals - 
Proposal for a New Guideline, Calanoid Copepod Development and Reproduction Test 
with Acartia tonsa, is a major outcome of this study, which is of particular importance 
for environmental risk assessment of chemicals. 
Effects observed in in vivo tests on its own does not necessarily allow conclusions with 
regard to the mode of toxic action. For this reason, complementary tests with the 
ecdysteroid-sensitive Drosophila  melanogaster BII cell line bioassay were conducted to 
discriminate between general and ecdysteroid-mediated toxicity. The pentabrominated 
diphenyl ethers BDE-99 and BDE-100 have shown to be weak ecdysteroid antagonists. 
This demonstrates the capability of these PBDEs to interfere with a fundamental 
physiological mechanism in arthropods, a property only known for a very few 
substances and provides evidence that the two penta-BDEs, BDE-99 and –100 may be 
considered as potential endocrine disrupters in invertebrates. 
When testing for endocrine disruption, it is important to remember that many effects on 
endocrine regulated processes can occur via mechanisms other than endocrine 
disruption. For example, a substantial part of crustaceans’ physiology is directed 
towards molting, therefore, almost any chemical, which adversely affects crustaceans 
can directly or indirectly disrupt molting. In sublethal toxicity tests with small 
crustaceans like copepods, the observed effects on development, growth and 
reproduction are not necessarily caused by disrupting the hormonal control of these 
processes, but may be due to other specific mechanisms or just due to general toxicity. 
Hence, a chemical cannot thus be classified as endocrine disrupter, unless first certain 
that the chemical in question is not simply a general toxicant. To understand the toxic 
mode of action behind effects of potential EDCs observed in vivo, in vitro methods, e.g. 
receptor-binding assays, are useful. On the other hand, such assays do not taking into 
account processes like bioaccumulation or metabolism of xenobiotics within an exposed 
animal. 
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Therefore, there is an urgent need to develop test strategies enabling to discriminate 
between endocrine-mediated and other toxic effects. Further research on the endocrine 
system of crustaceans is needed to better understand the mechanisms inducing sublethal 
toxicity. The combination of in vitro methods and (sub)chronic copepod bioassays, as 
applied in this study, can provide useful information in this context.  
Irrespective of the mode of action of a chemical it is simply important to know for the 
purpose of environmental risk assessment that there are chemicals that produce chronic 
effects at very low concentration levels, which will not be indicated by the 
ecotoxicological standard protocols typically applied. Thus, new methodologies have to 
be developed to overcome this fatal problem. The results of this study provide an 
important contribution to the transfer of knowledge from research laboratory to routine 
laboratory by providing draft protocols for OECD guidelines on a development and 
reproduction test with A. tonsa and a full life-cycle test with N. spinipes. 
Finally the following approach is suggested how to proceed when testing a chemical 
suspected to be specifically toxic, and/or in particular to interfere with the endocrine 
system: The chemical to be tested is subjected to acute and subchronic screening tests 
(e.g. 48h acute toxicity test/larval development test with A. tonsa) complemented by an 
in vitro bioassay with the ecdysteroid-sensitive D. melanogaster BII cell line. If the 
acute-to-chronic toxicity ratio is above ten and/or the BII bioassay indicates ecdysteroid 
(ant)agonistic activity, a full life-cycle test e.g. with A. tonsa, has to be applied. 
A real challenge in future research on endocrine disruption in crustaceans and other 
invertebrates is to get a deeper insight in their complex endocrine systems. In a recent 
review of nearly 75 years of crustacean endocrinological studies [51], Fingerman 
concluded that the work in this field “has really just begun”. 
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